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PREFACE
 After completing my studies abroad I returned to Norway without any 
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the ﬁrst PET research group in Norway along with an opportunity to conduct a 
Ph.D I couldn’t resist. In May 2005 I started at the Small Animal Imaging Unit 
located at the Neural Systems and Graphics Computing Laboratory (NeSys) at 
the Department of Anatomy, Institute of Basic Medical Sciences, University of 
Oslo. In April 2006 I was enrolled in the Ph.D program with fundings from the 
Research Council of Norway. 4 years later I am happy and proud to submit my 
Ph.D thesis. These years have consisted of challenges; which is a consequence 
of starting up with a new technology, excitements; by obtaining new knowledge 
and succeeding by having papers published, and travelling; to places such as 
London, Heidelberg, Munich, Atlanta, Espoo, Stockholm, Osaka, Tuebingen, 
Glasgow, Kobe and Chicago. Coming from a background in physics, a whole 
new world has revealed itself for me during this project. I have been introduced 
to the world of molecular biology, neuroscience, neuroimaging, neuroinformat-
ics, and radiochemistry. 
 This work would not have been completed without my three supervi-
sors: Johannes Gjerstad, Jan G. Bjålie, and Frode Willoch. I would like to thank 
Johannes for his enthusiasm and support, Jan for being solution oriented and 
his straightforward thinking, and Frode for believing in me and teaching me the 
world of imaging and pain.
 This project has been generously founded by the Research Council of 
Norway and the University of Oslo. 
 I want to acknowledge Prof Markus Schwaiger for the use of the small 
animal imaging facilities at Department of Nuclear Medicine at the University 
of Munich, together with his excellent technical staff. Gjermund Henriksen and 
Bent W. Schoultz for involving me in their reseach and miraculously producing 
the radiochemical substances which are crucial in PET research. I would also 
like to thank Trygve Leergaard for his supervision in preparing written and oral 
presentations and for organizing the annual NeSys sailcruises. My “ofﬁce mates” 
Hong Qu for the endless hours behind the shower curtains, for her straightforward-
ness and critical comments, and Dmitri Darine for being my computer wizard, 
Ph.D thesisiv
feeding me dark chocolate, and our discussions about anything non-scientiﬁc. 
Line Jacobsen at STAMI for excellent electrophysiological measurements and 
collaboration. All my co-authors which have played an important role in the indi-
vidual studies. Further I would like to thank all former and current colleagues at 
Nesys for interesting scientiﬁc and non-scientiﬁc discussions, ski trips, dinners, 
and chocolate Fridays. Also, I truly appreciate the excellent scientiﬁc environ-
ment of the Centre of Molecular Biology and Neuroscience (CMBN). Last but 
not least, I am grateful for the support of friends and family and their persistent 
attempts to understand my work. 
    
Oslo, September 2009 
Trine Hjørnevik
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Introduction
 Although acute pain is a necessity 
for survival, long-lasting pain, which 
persists longer than the natural time for 
healing, has no adaptive function and 
causes disease and strain on both the 
patient and society. Studies show that 20 
% of Europe’s adult population suffers 
from hypersensitivity, hyperalgesia, and 
allodynia. This thesis aims to contribute 
to a better understanding of the mecha-
nisms underlying the development of 
long-lasting pain. Positron Emission 
Tomography (PET) was employed to 
study supraspinal functional changes 
in a rat model of persistent pain (papers 
II and IV), together with a customized 
digitalized atlas system which provided 
localization of the PET signals (paper 
I). In addition, this work also encom-
passes the development and evalua-
tion of two novel PET tracers aimed 
for investigations of the endogenous 
opioid receptor (OR) system (papers III 
and V), which is a major neurotransmit-
ter system involved in pain processing. 
Below, some theoretical background is 
given together with the speciﬁc aims of 
the present work.    
PAIN PERCEPTION AND 
MODULATION
 Pain is a subjective perception 
of nociceptive signal input mixed with 
emotions and previous experiences. 
From the peripheral nervous system 
(PNS) nociceptive information is trans-
mitted through C- and Aδ-nociceptors 
to the dorsal horn (DH) of the spinal 
cord, and from there, through second 
order neurons, to supraspinal regions 
where the signal is interpreted. There 
are several ascending pathways, includ-
ing the main spinothalamic tract, spi-
nomesencephalic tract, and spinore-
ticular tract. Brain regions involved 
in pain processing include the sensory 
cortex, anterior cingulate cortex, thala-
mus, and limbic structures. Belonging to 
the latter category, nucleus accumbens 
(Acb), amygdala, hippocampus, hypo-
thalamus, and caudate putamen (CPu) 
are all involved in processing emotions, 
mood, motivation, and pain sensations. 
Involvement of these structures reﬂects 
an affective-emotional response to a 
noxious event. Together with the hip-
pocampus, amygdala is also involved 
in learning and memory of noxious 
stimuli. In particular, amygdala plays 
a major role in associating the stimuli 
with emotions, and might contribute to 
the formation of “pain memory”.
 The idea of pain modulation was 
introduced by Head and Holmes as early 
INTRODUCTION
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Figure 1. Descending noci-
ceptive modulation. Amyg-
dala, PAG, RVM, and DLTP 
constitute a major descending 
pain modulatory network. 
There are reciprocal projec-
tions between the midbrain 
region PAG, and DLTP and 
RVM in the brain stem. RVM 
and DLTP exert control over 
nociceptive transmission in 
the dorsal horn of the spinal 
cord. PAG, periaqueductal 
grey; DLPT, dorsolateral pon-
tine tegmentum; RVM, rostral 
ventromedial medulla. 
as 1911, but ﬁrst in 1965 the existence of 
a speciﬁc pain modulatory system was 
articulated by the famous “Gate Con-
trol Theory” by Melzack and Wall [27]. 
Nociceptive transmission is ﬁltered and 
modulated by interneurons either locally 
in the DH or in descending pathways 
to the spinal cord. These interneurons 
either suppress (descending inhibition) 
or potentiate (descending facilitation) 
nociceptive signaling to the brain. Today, 
complex networks are known to play a 
crucial role in pain modulation, and the 
best described network is the descending 
nociceptive inhibitory circuitry (DNIC) 
which includes the amygdala, periaque-
ductal grey (PAG), rostroventromedial 
medulla (RVM), and dorsolateral pon-
tine tegmentum (DLPT) (Fig. 1) [8]. 
These brain and brain stem structures 
control nociceptive transmission in the 
spinal cord by inhibiting nociresponsive 
neurons in the dorsal horn. A dysfunc-
tion in this inhibitory system could cause 
a reduced antinociceptive effect, which 
might lead to an increased activity in 
the ascending second order neurons. 
This hypothesis has been investigated 
Ph.D thesis4
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in papers II and IV. The complexity of 
this pain-control network involves sev-
eral neurotransmitters and their speciﬁc 
receptors (for review see [29]), but this 
thesis will, in paper IV, focus on the OR 
system which plays a key role in pain 
inhibition.
NEUROIMAGING OF PAIN
 In vivo functional neuroimaging 
by means of PET and functional mag-
netic resonance imaging (fMRI) have 
contributed to increased knowledge of 
the functional anatomy of pain. In vivo 
non-invasive imaging facilitates longi-
tudinal investigations, where the pain 
matrix can be studied as a whole, reveal-
ing interactions between brain regions, 
and not just the effect on individual 
regions. PET was chosen as method in 
the present study based on high sen-
sitivity and its unique ability to local-
ize and quantify speciﬁc neuroreceptor 
systems. Further information about the 
PET technology and areas of application 
is given in Methods. Currently, PET is 
used comprehensively in clinical studies 
of various pain models (for review see 
[38]), but few studies based on animal 
research have been published. The pres-
ent thesis utilizes PET scanners dedi-
cated for imaging of small animals to 
study supraspinal functional changes in 
a rat model of persistent pain. 
 
CENTRAL SENSITIZATION AND 
LONG-TERM POTENTIATION 
 Central sensitization is deﬁned 
by the International Association for the 
Study of Pain (IASP) as “an enhanced 
responsiveness of nociceptive neurons 
in the central nervous system (CNS) to 
their afferent input” [28]. Some forms of 
central sensitization may cause enhanced 
pain experience to a noxious stimulus 
(hyperalgesia) or a non-noxious stimulus 
to be experienced as painful (allodynia) 
or both. 
 It has been suggested that induc-
tion of long-term potentiation (LTP) by 
noxious stimuli (e.g. electrical stimuli, 
noxious heat, nerve injury, and tissue 
damage) [46,49] is one mechanism 
underlying hypersensitivity, hyperalge-
sia, and allodynia [48]. LTP is deﬁned as 
a long-lasting increase in neuronal syn-
aptic strength [1,25], and is considered 
to contribute to learning and memory 
formation in the brain [1]. In the pres-
ent thesis, a rat model was utilized for 
investigating the correlation between 
spinal LTP and supraspinal nociceptive 
processing. Spinal LTP was induced 
by high-frequency stimulation (HFS) 
conditioning applied to the rat sciatic 
nerve, which is an established model for 
Trine Hjørnevik 5
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studying cellular memory of nociceptive 
information. It is tempting to speculate 
that the applied conditioning not only 
induces LTP at the spinal level, but also 
at supraspinal synapses. Particularly in 
brain regions included in the pain neu-
romatrix such as the sensory cortex, 
thalamus, cingulated cortex, and PAG. 
Spinal LTP is here deﬁned as C-ﬁbre 
LTP, which represents an increase in 
C-ﬁbre response (measured in papers 
II og IV) together with a reduction in 
C-ﬁbre threshold (paper IV). A lower-
ing of the C-ﬁbre threshold will result 
in second order neurons (i.e. neurons 
which transmit signals from the spinal 
cord to supraspinal sites) ﬁring at lower 
input frequencies. Spinal LTP has been 
shown to last for hours [54] and if such 
a long-lasting increase in the respon-
siveness of nociceptive neurons persists 
it might result in central sensitization. 
Evidence indicate that induction of spi-
nal LTP is followed by a long-lasting 
ipsilateral reduction of paw withdrawal 
latency, i.e. hyperalgesia [62]. Moreover, 
a perceptual correlate to LTP in nocicep-
tive pathways has also been described 
in humans [20]. It is therefore likely 
that the conditioning used in the present 
thesis to induce spinal LTP contribute 
to central sensitization, an underlying 
mechanism of hypersensitivity, hyper-
algesia, and allodynia. 
THE OPIOID RECEPTOR SYSTEM
 The ORs are widely distributed in 
the CNS and are divided into three major 
subtypes (i.e. μ, δ, and κ) in addition 
to the opioid-receptor-like NOP [15]. 
Rat brain regions which contain dense 
distributions of ORs include the neocor-
tex, CPu, thalamus, Acb, hippocampus, 
amygdala, and inferior/superior colliculi 
[26]. Activation of ORs, by endogenous 
or administrated exogenous ligands, 
contribute to functional changes in areas 
such as pain and analgesia, tolerance and 
dependence, learning and memory, and 
alcohol and drug abuse (for review see 
[16]). 
 The present thesis (paper IV) 
focuses on the role of ORs in noci-
ceptive processing, where the opioid 
peptides (OPs), such as β-endorphin, 
enkephalin, and dynorphin, are key neu-
rotransmitters involved in nociceptive 
signaling mechanisms and in controlling 
the descending modulatory system to the 
spinal cord. The ORs play an important 
role in affective-emotional processing 
and antinociception, and particularly 
μ-OR activation seems to be important 
for the mechanisms underlying opioid 
analgesia [7,26]. Also δ- and κ-ORs 
are most likely involved in modulating 
Ph.D thesis6
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supraspinal nociception, where the lat-
ter subtype is believed to suppress the 
antinociceptive action of the μ-OR (for 
review see [43]). However, the relative 
low abundance of κ-ORs (9 %) com-
pared to μ-ORs (41 %) [26] in the rat 
brain limits this pronociceptive effect in 
rats. Changes in endogenous opioider-
gic signaling might inﬂuence various 
molecular mechanisms seen in chronic 
pain states where persistent noxious 
stimuli have been shown to result in 
changes in opioid action (for review see 
[41]).
AIMS OF STUDY
The following main questions were addressed in the present thesis:
Can small animal PET be used to measure putative supraspinal 1) 
functional changes associated with spinal LTP induced by noxious 
conditioning?
Can a multi-modality 3-D digital atlas system improve signal local-2) 
ization and enhance the interpretation of tomographic data, such as 
PET images, with low structural contrast? 
Does spinal LTP have a long-lasting effect on supraspinal neuronal 3) 
metabolic activity?
Can the development of novel PET tracers facilitate preclinical 4) 
and clinical studies of various subclasses of the endogenous OR 
system? 
Does spinal LTP inﬂuence supraspinal opioidergic 5) 
neurotransmission?
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Methods
 All animal experiments were per-
formed in conformity with the laws and 
regulations controlling experiments and 
procedures on live animals in Norway, 
Germany and Japan, which is in accor-
dance with the European convention for 
the protection of vertebrate animals used 
for experimental and scientiﬁc purposes. 
Details concerning the experimental and 
analytical procedures are described in the 
individual papers. This section will ﬁrst 
provide an overview of the employed 
methods; imaging techniques, electro-
physiology recordings, multi-modality 
co-registration, and computerized 3-D 
reconstruction. Then, more details will 
be given about the two main methods 
utilized in the present thesis: PET and 
digital atlasing.   
OVERVIEW OF METHODS
Induction of spinal LTP
 Experimental data show that LTP 
is induced by various noxious stimuli 
including electrical conditioning, nox-
ious heat, nerve injury, or tissue damage 
[46,49]. In the present thesis (papers 
II and IV), LTP was induced by HFS 
conditioning (1 ms rectangular 4.5 mA 
pulses, ﬁve trains of 1 s duration, 100 
Hz, 10 s intervals between trains). Dur-
ing adequate anesthesia, the left sciatic 
nerve was dissected free and isolated 
from the surrounding tissue. An elec-
trode was placed proximal to the main 
branches of the sciatic nerve for electri-
cal stimulation. 
 
Electrophysiological recordings
 Recordings of spinal ﬁeld poten-
tials were applied, in papers II and IV, 
in order to verify that spinal LTP was 
induced by HFS conditioning of the 
sciatic nerve. The measurements were 
based on the C-ﬁbre response to a test 
pulse, in addition to the lowest stimu-
lus intensity that evokes the ﬁrst visible 
C-ﬁbre response, i.e. C-ﬁbre threshold 
(paper IV).  
Tomographic neuroimaging 
techniques
 Neuroimaging techniques such as 
PET and magnetic resonance imaging 
(MRI) provide in vivo functional and 
structural information about the mouse 
and rat brain. PET reﬂects function, 
while MRI reveals both anatomical and 
functional information depending on the 
imaging paradigm used. The present 
thesis focuses on PET imaging, while 
MRI is utilized as an anatomical refer-
METHODS
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ence (papers I, II, IV, and V), and for 
exemplifying the use of a digital atlas 
system in order to localize enhanced 
MRI signals (paper I). 
  
Magnetic Resonance Imaging (MRI)
 MRI offers good soft tissue con-
trast in the rat brain, and is therefore 
often used as an anatomical reference 
for the functional signals obtained with 
PET. An MRI template ﬁtted to Paxi-
nos and Watson atlas space [51] was 
in papers I, II, and IV used to spatially 
normalize PET data into a common ref-
erence framework. 
 In paper I, high-resolution in vivo 
MnCl2/MRI pathway tracing was used 
as an example of how a digital atlas 
could assign location to tracer injection 
sites and observed signal enhancements. 
The T1 weighted data was collected at 
the Massachusetts General Hospital 
NMR-Center using a 3 Tesla Trio whole 
body human scanner (Siemens Medical 
Solutions, Iselin, NJ) and a custom made 
loop surface receiver coil.
 
Positron Emission Tomography (PET)
 PET is the state of the art imag-
ing technology for studying biological 
processes in vivo. In the present thesis, 
PET was used for studying nocicep-
tive processing in the brain in papers I, 
II, and IV, cancerous tissue in paper I, 
and speciﬁc neurotransmitter system in 
papers I, III, IV, and V. The PET data 
presented in papers I and II was acquired 
with the microPET Focus 120 system 
(Siemens Medical Solutions, Erlangen, 
Germany) at the Small Animal Imaging 
Unit at University of Oslo, the PET data 
in papers III and IV was collected with 
the Inveon system (Siemens Medical 
Solutions, Erlangen, Germany) at Tech-
nische Universität München, while the 
PET imaging in paper V was performed 
with the SHR-770 (Hamamatsu Photon-
ics, Hamamatsu, Japan) at the Medical 
and Pharmacological Research Center 
Foundation Hakui-city Ishikawa. Fur-
ther information about PET imaging is 
given in a separate subsection.   
Software
 The following software packages 
were used for image analysis and atlas 
reconstruction:
Adobe Illustrator CS2•  (Adobe 
Systems Inc., San Jose, Ca): atlas 
alignment and segmentation.
Amira 4.0•  (Mercury Computer 
Systems Inc., Chelmsford, Ma): 
3-D atlas surface rendering.
PMOD•  (PMOD Technologies 
Ltd., Zurich, Switzerland): image 
pre-processing, multi-modality co-
Trine Hjørnevik 9
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registration, and pharmacokinetic 
modeling. 
Statistical Parametric Mapping•  
(SPM5, Wellcome Department of 
Cognitive Neurology, Institute of 
Neurology, London, Uk) performed 
in Matlab 7.5.0 and 7.6 on Win-
dows and Mac OS workstations: 
multi-modality co-registration and 
normalization, and statistical anal-
ysis. The SPM5 software is freely 
available at http://www.ﬁl.ion.ucl.
ac.uk/spm. 
Atlas3D•  (NeSys, Department of 
Anatomy & CMBN, University 
of Oslo, Norway): This multi-
platform Java3D based atlas tool 
was developed in our group to 
facilitate import and visualization 
of 3-D digital atlas structures as 
well as tomographic image data 
(i.e. PET, CT, and MRI). In addition 
to co-visualization, a cutting 
module, i.e. 2-D user-deﬁned slices 
at any angle and orientation, was 
developed. The software is freely 
available at http://www.nesys.uio.
no/Atlas3D. 
Multi-modality co-registration and 
spatial normalization
 To improve interpretation of the 
functional signals seen in our PET data, 
MRI, CT, and atlas were utilized as 
structural references. In order to locate 
the signal, the various modalities were 
co-registered and normalized to the 
same reference space.  
Co-registration of PET, MRI, and CT 
data
 In papers I, II, and IV, automatic 
intra-subject co-registration and spa-
tial normalization between various 
image data were performed in SPM5. 
The within-subject co-registration was 
based on a rigid body model involving 3 
translations and 3 rotations using a nor-
malized mutual information objective 
function. Normalization was performed 
with a linear registration which employs 
a 12-parameter afﬁne transformation 
procedure. 
3-D atlas reconstruction
 A 3-D digital atlas system was 
developed to facilitate assignment of 
location and comparative analysis of 
signal location in tomographic images 
with low structural contrast. The 3-D 
atlas structures were reconstructed from 
standard 2-D mouse and rat brain atlases. 
The reconstruction steps included align-
ment of atlas diagrams, segmentation, 
and surface rendering. Further details on 
the digital atlas system are given else-
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where in this section.   
Registration to 3-D atlas space
 Tomographic imaging data (PET, 
CT, and MRI) were manually co-regis-
tered to the 3-D atlas space in Atlas3D 
based on identiﬁable landmarks in the 
various data. The most limited amount 
of structural information is available 
in PET data, and therefore additional 
imaging modalities can improve the 
quality of the registration. Throughout 
this project, three particular pipelines 
have been utilized and validated; 1) co-
registration of PET to atlas (paper I), co-
registration of PET through MRI to atlas 
(papers I and II) and 3) co-registration 
of PET through CT to atlas (papers I 
and IV). The anatomical landmarks used 
for registration in the various cases are 
discussed in the individual papers. Also, 
in paper I, atlas co-registration was used 
for locating tracer injection sites and 
observed signal enhancement in a high-
resolution in vivo MnCl2/MRI pathway 
tracing study.
 
POSITRON EMISSION TOMOGRAPHY
 PET is a unique imaging modality 
for studying functional processes in vivo. 
With high sensitivity and quantitative 
abilities PET has become an important 
research tool, as well as a routine diag-
nostic modality. The ﬁrst human PET 
tomograph was developed in 1974 and 
marks the beginning of the modern PET 
technology [32]. In the recent years, 
PET scanners with improved sensitiv-
ity and resolution dedicated to imaging 
small animals have been developed to 
study animal models of disease. One of 
the early designs was the UCLA micro-
PET [5], which is the prototype for the 
commercially available small animal 
PET scanners used in this thesis. 
The basics of PET: positron emission, 
detection, and image reconstruction
 PET imaging involves adminis-
tration of a radiopharmaceutical, labeled 
with a positron emitting radionuclide, 
into a subject and external detection of 
annihilation photons using detectors 
in combination with coincidence elec-
tronics. During positron (β+) decay, a 
proton is converted into a neutron, and 
a positron and a neutrino are emitted 
from the nucleus. The positron loses 
kinetic energy through interactions with 
the surrounding tissue until it annihilates 
with an electron. The total rest masses 
of the two particles are then converted 
into electromagnetic radiation, creat-
ing two annihilation photons of equal 
energy (511 ± 1 keV) travelling 180 º to 
each other (Fig. 2). The positron range 
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Table 1. Properties of the main positron-emitting nuclides.
Nuclide 11C 13N 15O 18F
Half life (min) 20.4 9.9 2.1 109.8
Emax (MeV) 0.959 1.197 1.738 0.633
Mean range in water (mm) 1.1 1.5 2.5 0.6
Figure 2. Positron emission, annihilation, 
and detection. The positron is emitted from 
an unstable nucleus, and annihilates with an 
electron after interacting with the surrounding 
tissue. The two particles are converted into two 
photons (γ-rays) of equal energy (511 keV) 
traveling 180 º to each other. Simultaneous 
detection of these photons creates a coinci-
dence event and a line-of-response (LOR).   
(i.e. travelling distance before annihila-
tion) depends on the initial energy of the 
positron and the density of surround-
ing tissue. The properties of the most 
important positron emitters used in PET 
are listed in Table 1. In this thesis, 18F 
was used in papers I and II, and 11C in 
papers III-V. The long half life of 18F 
facilitates more ﬂexible study protocols 
and improved statistics.
 The standard geometry of a PET 
scanner is a ring of detectors, employing 
coincidence electronics, which enables 
detection of the simultaneously emitted 
annihilation photons. If both photons 
are detected within limits of timing- and 
energy-windows, a line-of-response 
(LOR) will pass close to the site of anni-
hilation representing the site of positron 
emission (Fig. 2), and hence the injected 
probe. 
 Acquired data is, in certain PET 
tomographs including the microPET 
Focus 120 and Inveon, written in a list 
mode data format, which allows the user 
to dynamically divide the experimental 
data into customized time frames. To 
obtain images, each time frame is his-
togrammed into sinograms and recon-
structed using various image reconstruc-
tion algorithms; e.g. analytical methods 
such as the traditional ﬁltered back-
projection (FBP) and 3D reprojection 
(3DRP), or iterative methods such as 
ordered subsets expectation maximiza-
tion (OSEM3D) and OSEM3D - maxi-
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mum a posteriori (OSEM3D/MAP). The 
latter algorithms facilitate advantages 
such as noise modeling, incorporation of 
image degrading effects, and corrections 
due to variations in scanner geometry, 
but are limited by long computational 
time. In the present work, based on the 
features offered by the individual soft-
ware, both analytical and iterative recon-
struction algorithms have been used; 
2DFBP (paper V), 3DRP (papers III and 
IV) and OSEM3D/MAP (papers I and 
II).  
 To obtain quantitative measure-
ments (i.e. accurate reconstruction of 
radiotracer concentration (kBq/ml)), 
several corrections must be applied to 
the raw image data during reconstruc-
tion; e.g. scatter, normalization, and 
attenuation corrections. The latter cor-
rects for photon attenuation due to scat-
ter or absorption in tissue. In the micro-
PET Focus 120 and Inveon system the 
attenuation correction is performed by 
acquiring a transmission scan by either a 
positron emitter source, 68Ge, or a single 
photon emitter, 57Co.  
Applications of PET 
 Areas of clinical applications and 
basic research include neurology, oncol-
ogy, cardiology, and pharmacology. The 
main focus of this thesis is imaging of 
neurochemical processes in the brain, an 
area which offers a relative large spec-
trum of available tracers. 
FDG-PET
 The glucose analog 2- [18F]ﬂuoro-
2-deoxy-glucose ([18F]FDG) (used in 
papers I-II) has been utilized since the 
late 70s and is the most commonly used 
molecular probe in PET imaging. The 
basis for FDG imaging is the coupling 
between glucose utilization and synap-
tic activity (neurometabolic coupling) 
[52]. In paper I, FDG was utilized for 
illustrating increased metabolic activity 
in cancerous tissue compared to normal 
tissue, while, in papers I and II, the use 
of FDG facilitated comparisons between 
baseline and noxious conditioning at 
different time points. 
Ligand-PET
 PET is the state of the art imaging 
modality for studying receptors systems 
in vivo with the use of highly selective 
receptor radiotracers. [18F]fallypride 
(paper I, [30]) is a highly selective D2/
D3 dopamine receptor antagonist often 
used to explore changes in the dopamin-
ergic system. During the baseline condi-
tions in paper I, [18F]fallypride was used 
to reveal distributions and concentra-
tions of the dopamine receptors in the 
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rat brain. The present thesis focuses on 
the endogenous opioid system, and PET 
imaging of ORs has provided impor-
tant insights into the areas of epilepsy, 
pain processing, neurodegenerative 
disorders, addiction, and new pharma-
cological treatments (for reviews see 
[10,16,43]).
  Several PET ligands have been 
developed with different tracer proper-
ties and subclass selectivity; e.g. the 
μ-selective agonist [11C]carfentanil 
([11C]CAF), non-selective antagonist 
[11C]diprenorphine ([11C]DPN), and 
μ- and κ-selective antagonist [18F]ﬂu-
oro-cyclofoxy ([18F]FCyF). The highly 
potent agonist [11C]CAF has been used 
in human studies of μ-ORs since 1985 
[9], but high speciﬁc activity is needed 
to obtain sub-pharmacological doses. 
Also, it is believed that agonist trac-
ers reﬂect endogenous binding more 
speciﬁcally than antagonists. Develop-
ment of structurally matched agonist/
antagonist pairs will facilitate testing 
of such a hypothesis. Therefore, an ago-
nist radiotracer, [11C]phenethyl-orvinol 
([11C]PEO), has been synthesized and 
characterized in paper III. [11C]PEO 
binds selectively to μ- and κ-ORs, is 
less potent than the traditional [11C]CAF, 
results from a fairly fast synthesis, and 
future developments such as [18F]label-
ing and production of an antagonist ver-
sion are more easily implemented. The 
present thesis focuses on the role of ORs 
in pain processing, and the novel opioid 
PET tracer was, in paper IV, employed 
to investigate dynamic changes in opioid 
neurotransmission following noxious 
stimulus-induced spinal LTP. The ago-
nistic properties along with high afﬁnity 
for the μ-OR determined the choice of 
tracer in this study.  
 Currently, no κ-OR-selective 
PET-tracer is available for routine 
clinical applications. [11C]GR103545 
is a promising κ-OR-selective tracer 
[45,57] which facilitates high afﬁnity 
and excellent binding to κ-ORs in the 
non-human brain. However, the use of 
[11C]GR103545 in clinical studies has so 
far been limited due to low radiochemi-
cal yield.  An improved and automated 
method for radiosynthesis of [11C]
GR103545 was introduced by Schoultz 
et al. [50], and paper V evaluates the use 
of [11C]GR103545, synthesized by the 
new method, in rhesus macaques.
  
Quantiﬁcation 
 In order to fully interpret the exter-
nally detected PET signal, quantiﬁcation 
of the time course of the radiolabeled 
substance is necessary. This is particu-
larly important in neuroreceptor imag-
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Figure 3. Pharmacokinetic modeling. Various models, based on the ratio of concen-
trations in tissue (CT) and plasma (CP), provide an estimation of the speciﬁc binding 
of tracer. In standard compartment models (1TCM and 2TCM) blood sampling is 
required to determine CP, while in a reference tissue model this input function is 
substituted with CT from a reference tissue avoid of speciﬁc binding. 1TCM, 1-tis-
sue compartment; 2TCM, 2-tissue compartment; K1, k2, k3 and K4, exchange rates 
between compartments. 
ing, where the total detected signal is 
“contaminated” by free ligand in tissue 
and non-speciﬁcally bound ligand. The 
standard way of estimating the compo-
nent-of-interest, the speciﬁcally bound 
ligand, is by pharmacokinetic modeling 
using compartment models (for reviews 
see [12,19]). Each compartment repre-
sents a certain behavioral state of the 
tracer, and may exchange material with 
other compartments (exchange rates are 
indicated as K1, k2, k3 and k4 in Fig. 3). 
Compartment modeling requires blood 
sampling for estimation of tracer con-
centration in plasma, which also needs 
to be corrected for metabolites. Ideally, 
a 3-tissue compartment model (3TCM), 
containing one compartment for each 
behavioral state of the tracer, should be 
used for reversible receptor systems, but 
the complexity of such a model is difﬁ-
cult to assess experimentally. For practi-
cal purposes, free and non-speciﬁcally 
bound tracer is treated as one compart-
ment in a 2-tissue compartment model 
(2TCM) (Fig. 3). Further simpliﬁca-
tion into a 1-tissue compartment model 
(1TCM) is sometimes necessary in order 
to reduce the number of unknown param-
eters (i.e. exchange rates). In paper V, 
Trine Hjørnevik 15
Methods
both 1TCM and 2TCM were used in 
the κ-OR speciﬁc binding analysis in 
the monkey brain study. The estimated 
parameter of interest, volume-of-distri-
bution (VT), in both models, is equal to 
the ratio of tissue (CT) and plasma (CP) 
concentrations at equilibrium. 
 Compartment modeling requires 
invasive blood sampling which can, par-
ticularly in rodent imaging, be quite a 
demanding procedure. Therefore, ref-
erence tissue models have been devel-
oped where the arterial input curve 
is substituted with the time activity 
curve of some reference tissue avoid 
of speciﬁc binding. The detected sig-
nal from such a reference tissue pro-
vides an estimation of the non-speciﬁc 
binding and free tracer in tissue (Fig. 
3), which is assumed to be equal in all 
tissue. Although these models do not 
provide a full kinetic analysis, they are 
able to estimate valuable measures of 
interest. In paper IV, speciﬁc OR bind-
ing was quantiﬁed pixel-by-pixel using 
the Ichise Multi-linear Reference Tissue 
Method (MRTM0) [18]. This reference 
model is based on the Logan Plot [23] 
and applies for reversible receptor stud-
ies. The output parameter of interest 
is the binding potential (BPND), which 
provides a measurement of receptor con-
centration. The cerebellum was chosen 
as the reference tissue due to the lack 
of ORs in this region for the rat [26]. 
BPND is proportional with the ratio of 
the concentration of available receptor 
sites (Bmax) to the in vivo equilibrium 
dissociation constant of the radiotracer 
(KD).
3-D DIGITAL ATLAS SYSTEM
 Brain atlases are extensively used 
in neuroscience for identifying anatomi-
cal structures in the brain. Conventional 
two-dimensional (2-D) book atlases pro-
vide series of sections, cut at speciﬁed 
angles and arranged in a standard ste-
reotaxic framework based on reference 
external and internal landmarks or both. 
Several of the most commonly known 
rodent brain atlases [35-37] use a stereo-
taxic reference system based on the ﬂat-
skull positions with the bregma, lambda, 
and interaural line as landmarks. 
 Use of such atlases for neuroimag-
ing data is hampered by the 2-D format 
as well as a lack of an analytical envi-
ronment for comparison and integration 
of atlas and image data. Computerized 
3-D atlases provide volumetric repre-
sentation of brain anatomy, in addition 
to slicing at all angles and orientations, 
generating customized atlas diagrams 
which are more compatible with individ-
ual image data. Several 3-D representa-
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Figure 4. Workﬂow for 3-D atlas re-
construction.
The stepwise procedure is based on a stan-
dard 2-D atlas diagram which is segmented 
according to individual brain regions and 
then 3-D reconstructed. The 3-D atlas can 
be sliced at any angles and orientations to 
create customized atlas diagrams. 
Methods
tions of major brain structures have been 
developed for the mouse [2,4,14,22,24], 
and are under development for the rat 
(see e.g. [13,14]). In addition to be used 
as references and analytical tools, digital 
atlases might also provide a framework 
for data sharing [3]. 
3-D atlas reconstruction
 In paper I, we presented a method 
for creating a 3-D computerized ste-
reotaxic brain atlas model from a 2-D 
stereotaxic book atlas. Our procedure is 
based on The Rat Brain in Stereotaxic 
Coordinates, 5th edition, by Paxinos & 
Watson [37] and the Mouse Brain in 
Sterotaxic Coordinates, 2nd edition, by 
Paxinos & Franklin [36], but could be 
applied to any digitalized stereotaxic 
atlas. The present versions of the 3-D 
reconstructed atlases include 30 struc-
tures for the mouse brain and 60 struc-
tures for the rat brain. 
 The method for 3-D reconstruc-
tion of the atlas structures is explored 
in detail in paper I. Figure 4 illustrates 
the applied pipeline. The digital atlas 
diagrams were organized in separate 
layers and aligned according to the ste-
reotaxic grid of the atlas using Adobe 
Illustrator CS2. In each diagram, regions 
of interest (ROIs) were segmented by 
colour coding, and then exported as an 
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image (TIFF) ﬁle to Amira 4.0 for 3-D 
reconstruction. All structures were sur-
face rendered and exported as VRML 
(Virtual Reality Modeling Language). 
The reconstructed atlas structures can 
be visualized in the custom made atlas 
tool, Atlas3D.
Methods
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SUMMARY OF PAPERS I-V 
Paper I
 Interpretation of tomographic neuroimaging data relies on accurate deter-
mination of anatomical location, which depends on the structural information 
available in the images. PET data and some MRI paradigms provide little struc-
tural contrast, and the challenge is therefore to assign locations to the data with 
use of available brain atlases. The comparison is hampered by the standard 2-D 
format of the atlas as well as a lack of an analytical environment for integration 
of atlas and 3-D image data. 
 We have developed a method for reconstructing 3-D atlases from any ste-
reotaxic 2-D atlas. Currently, our atlas system contains 30 mouse brain structures 
reconstructed from “The Mouse Brain in Stereotaxic Coordinates” by Paxinos 
& Franklin [34], and 60 rat brain structures from “The Rat Brain in Stereotaxic 
Coordinates” by Paxinos & Watson [35]. We have, furthermore, developed a 
multi-platform tool which allows sharing of the reconstructed atlas framework, 
surface modeling, rotation of selected structures, and slicing at any chosen angle. 
The tool allows import of PET, CT, and MRI data to facilitate comparison with 
the atlas and warping of experimental image data into atlas space. The approach 
taken uses linear registration, with the possibility to scale, rotate, and position 
Results
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the imported data, either globally, using the whole brain as template, or locally, 
using smaller parts of the brain as template.  
 The co-registration is based on recognizable brain or skull landmarks, 
which depends on the nature of the image data. A PET image volume typically 
lacks well-deﬁned structural information which may complicate the alignment. 
As illustrated in the paper, the quality of the co-registration may be enhanced 
when the researcher has access to other modalities such as MRI or CT or both. 
The alignment of an MRI volume is based on anatomical landmarks such as the 
outer boundaries of the brain and white matter. In a CT volume, the deﬁnition of 
bregma and the interaural line simpliﬁes the transformation matrix calculation. 
The accuracy of the co-registration critically depends on the precision with which 
anatomical landmarks may be detected, which in turn also depends on voxel size 
and structural contrast in the data. For the image quality here exempliﬁed, our 
linear procedures appear to provide sufﬁcient accuracy to resolve most questions 
related to localization of data and comparisons between animals.
Paper II
 LTP is deﬁned as a long-lasting increase in neuronal synaptic strength [1,24] 
and if induced by a noxious stimulus believed to contribute to hypersensitivity, 
hyperalgesia and/or allodynia [45]. In the present study we have investigated 
if noxious stimulus-induced spinal LTP might have a long-lasting effect on 
Results
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supraspinal neuronal activity. First, we veriﬁed that spinal LTP was induced by 
HFS conditioning as a noxious stimulus of the sciatic nerve. Then, to study the 
brain activation patterns following the same stimulation protocol, we used small 
animal PET and the glucose analog [18F]FDG. We hypothesized that immediately 
after a noxious stimulation an evoked signal would be observed predominantly in 
the ascending pathways, and that maintenance of spinal LTP would be followed 
by adaptations in the supraspinal pain modulating network.
 The spinal ﬁeld potential recordings revealed a twofold increase of the 
C-ﬁbre response 150 min after HFS. Changes in regional supraspinal neuronal 
activity were measured at two time points in HFS conditioned and sham animals; 
acute (immediately after HFS/sham) and late phase (150 min after HFS/sham). 
Statistical group comparison between HFS and sham revealed acute metabolic 
changes in S1 and slower metabolic adaptations in brain regions involved in 
modulation of nociceptive signaling, such as PAG, RVM, and DLPT. 
 We have here demonstrated that HFS conditioning of the sciatic nerve 
produced a clear LTP at the spinal level. This study demonstrates that PET is suit-
able as an in vivo method to study changes in regional brain metabolic activity 
between different conditions, and the observed changes within the CNS reﬂect 
a supraspinal maladaptive dysfunction involved in pain hypersensitivity and 
hyperalgesia.
Results
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Paper III
Results
 ORs are known to be involved in pain modulation [50,56] as well as being 
molecular targets of opioid and stimulant drugs of abuse [10,38]. Non-invasive 
imaging of the OR system by PET requires highly selective tracers which bind 
speciﬁcally to one or several subclasses (e.g. μ, δ, and κ) of the ORs. Currently, 
several non-selective OR-antagonists are employed for studies in humans. How-
ever, it is believed that antagonistic radioligands target other binding sites than 
agonists, and their ability to monitor in vivo OR occupancy is limited. Hence, 
high-afﬁnity agonistic radioligands are needed to obtain a detailed comparison 
of OR agonist/antagonist PET-tracers. 
 The present paper reports on a fully automated synthesis and character-
ization of agonist [11C]PEO. In vitro radioligand binding experiments revealed 
high-afﬁnity of [11C]PEO for μ- and κ-ORs, and low-afﬁnity for δ-ORs. Evalu-
ation of the radiotracer was performed with ex vivo biodistribution (with and 
without pre-treatment of blocking agents) and in vivo PET imaging experiments 
in rats. Both methods showed excellent initial brain uptake, and overtime, highly 
concentrated binding to brain regions where the μ-OR expression is richest. In 
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addition, metabolites analysis indicated high metabolic stability. 
 The agonist radioligand, [11C]PEO, presented in this paper was success-
fully prepared using a fully automated synthesis. The highly selective [11C]PEO 
depicts μ-ORs in the rat brain, and can be used to investigate changes in the OR 
availability during in vivo small animal PET studies.      
Paper IV
Spinal long-term potentiation is associated with reduced opioid 
neurotransmission in the rat brain
Hjornevik T, Schoultz BW, Marton J, Gjerstad J, Drzezga A, Henriksen G, and Willoch F
 OPs are key neurotransmitters involved in nociceptive processing in the 
brain and in controlling the descending modulatory system to the spinal cord. The 
ORs are widely distributed in the CNS and play an important role in affective-
emotional processing and antinociception. LTP induced by noxious stimulation 
in the pain pathways may be an underlying cellular mechanism underlying hype-
ralgesia, and the expression of spinal LTP is more pronounced when the connec-
tion between the brain and recording site in the spinal cord is eliminated [11,52]. 
In the present study we have examined if spinal LTP inﬂuences the supraspinal 
opioidergic system. First, we veriﬁed that spinal LTP was induced by electri-
cal HFS conditioning of the left sciatic nerve. Then, to study changes in opioid 
neurotransmission, we used small animal PET and the novel highly selective μ- 
and κ-OR ligand, [11C]PEO. We hypothesized that changes would occur in brain 
regions known to be involved in nociceptive responses, e.g. the limbic system, 
sensory cortex, thalamus, and PAG. 
 The spinal ﬁeld recordings showed a clear C-ﬁbre LTP, i.e. increased 
C-ﬁbre response and reduced C-ﬁbre threshold, 150 min after HFS condition-
ing. PET scans were acquired at baseline and 150 min after HFS conditioning. 
A measurement of receptor concentration, the BPND was calculated for each data 
set, and statistical group comparison (baseline vs. HFS) revealed a reduction in 
opioid neurotransmission in brain regions involved in limbic functions and pain 
modulation. 
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 Our ﬁndings indicate that a reduced descending opioid, antinociceptive 
activity may be related to the observed spinal C-ﬁbre LTP and associated states 
with abnormal pain sensitivity. Furthermore, the dynamic changes in opioid 
neurotransmission in the limbic structures may connect the ﬁndings with an 
affective-emotional response to the applied noxious stimulus. 
 
Paper V
Evaluation of the Kappa-Opioid Receptor Selective Tracer [11C]GR103545 
in Awake Rhesus Macaques
Schoultz BW*, Hjornevik T*, Willoch F, Marton J, Noda A, Murakami Y, Miyoshi S, 
Nishimura S, Årstad E, Drzezga A, Matsunari I, and Henriksen G
*Shared ﬁrst authorship
 Currently, no κ-OR-selective PET-tracer is available for routine clinical 
applications. A promising κ-OR-selective tracer, [11C]GR103545, was introduced 
by Ravert et al. [41,42], and evaluated in non-human primates by Talbot et al. 
[54]. They reported high afﬁnity and excellent binding to κ-ORs in the non-human 
primate brain. However, the low radiochemical yield limited the use of [11C]
GR103545 in clinical trials. A new and automated method for radiosynthesis of 
[11C]GR103545 was introduced by Schoultz et al. [47]. The improved method 
provided excellent yields with reduced total synthesis time. The present study 
evaluates the use of [11C]GR103545, synthesized by the new method, in awake 
rhesus macaques.
 In vivo PET imaging 0-90 min after injection of [11C]GR103545 in awake 
rhesus macaques showed excellent brain penetration and uptake patterns which 
correlated with known κ-OR distribution. The regional distribution volumes, VT, 
which were derived by kinetic analysis of regional time-activity curves (TACs) 
using 2TCM, was signiﬁcantly higher than reported by Talbot et al. [53], but with 
a consistent pattern. In addition, in vitro binding studies revealed high afﬁnity 
and excellent selectivity to κ-ORs. 
 The improved method for radiosynthesis of [11C]GR103545 enables the 
translation to clinical studies. The presented evaluation supports the role of [11C]
Results
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GR103545 as a promising tracer for selective depiction and quantiﬁcation of 
κ-OR by means of PET in humans. 
Results
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Discussion
 The main aim of this thesis was 
to investigate nociceptive signaling 
mechanisms in the rat brain using PET 
and digital atlasing. Two different PET 
tracers were used to study changes in 
regional neuronal activity and opioid 
neurotransmission following spinal LTP 
induced by noxious sciatic nerve condi-
tioning. A digital 3-D atlas system was 
developed to improve the interpretation 
of the PET signals. The main method-
ological considerations and implications 
of the ﬁndings are discussed below. 
MAIN FINDINGS
Referring to the main aims listed in the Introduction, the present thesis con-
tains the following main ﬁndings:
The results obtained in papers II and IV demonstrate that small animal 1) 
PET is suitable for detecting supraspinal changes in regional metabolic 
activity and opioid neurotransmission after induction of spinal LTP.
As demonstrated in paper I, registration of low structural contrast MRI 2) 
and PET data to a 3-D digital atlas framework facilitates assignment of 
signal location and comparative analysis of image data. The approach 
outlined was used in the PET data analysis in papers II and IV.   
In paper II, FDG-PET was used to identify acute activity changes and 3) 
slower metabolic adaptations in the brain, resulting from induced spinal 
LTP. These changes in metabolic activity were found in brain regions 
involved in modulation of nociceptive signalling.  
The fully automated radiosynthesis of the agonist [4) 11C]PEO introduced 
in paper III provides a highly selective μ- and κ-OR ligand which 
can be used to investigate changes to the OR availability during in 
vivo small animal PET studies. In addition, the evaluation, based on 
imaging studies in non-human primates, reported in paper V indicates 
that [11C]GR103545 is a candidate tracer for selective depiction and 
quantiﬁcation of  κ-OR in humans.    
 [5) 11C]PEO, a highly selective μ- and κ-OR ligand was used in paper IV               
DISCUSSION
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Discussion
METHODOLOGICAL 
CONSIDERATIONS
 The present thesis builds on the 
combined use of a number of methods, 
ranging from the development of novel 
opioid PET tracers to PET imaging stud-
ies with traditional and novel probes. 
In addition, a customized digital atlas 
framework was used for interpretation 
of the speciﬁc PET signals. Limitations 
and strengths of the methods employed 
in the present thesis along with the 
applied interpretation of image data are 
discussed below.
PET imaging
 Spatial resolution and interpre-
tation of signal. The amount of details 
which can be studied is limited by the 
spatial resolution provided by the PET 
modality. For dedicated high-resolu-
tion small animal scanners, the spatial 
resolution is dependent on the size of 
the crystal and the intrinsic resolution 
(i.e., positron range and photon non-
colinearity). For the small animal PET 
tomographs employed in this project, 
voxel sizes in the reconstructed images 
are ~1 mm3. Clusters of signal smaller in 
size will not be detected by the system 
and therefore result in false negative 
ﬁndings. 
 Further, for FDG-PET, increased 
signal activity resulting from increased 
metabolism is considered to be related to 
an increase in neuronal, synaptic activ-
ity. However, the functional nature of 
the increased activity is not well deﬁned, 
and can be caused by several functions 
related to e.g. on and off cells, excitatory, 
and inhibitory synapses. Consequently, 
the employed method is unable to deci-
pher the original nature of the increased 
signal activity.    
 Anesthesia. The choice of anes-
thetic agent is important for optimiz-
ing imaging protocols, and inhalation 
anesthesia such as isoﬂurane (utilized in 
papers I-IV) facilitates greater control 
over depth and duration of anesthesia. 
However, the physiological effects of 
anesthesia can inﬂuence the biodistri-
bution of PET tracers (for review see 
[17]). Toyama and colleagues reported 
to study changes in opioid neurotransmission 2.5 hrs after induction of 
spinal LTP. Reduced opioid tonic activity was found in brain regions 
involved in pain modulation, and in processing emotions, learning, 
and memory.
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a decrease in FDG uptake in the brain 
in mice anesthetized with isoﬂurane 
gas [59]. Nevertheless, since the FDG-
results presented in the present thesis 
are obtained from comparisons between 
two different conditioning states, the 
effect of isoﬂurane on FDG uptake can 
in this case be disregarded. The possible 
interaction by anesthetics is particularly 
important in neuroreceptor radioligand 
studies, where interference with the 
receptor system in question may alter 
the interpretation of data. Despite the 
importance, there are currently few 
studies which have thoroughly inves-
tigated the interference of anesthetics 
with radioligand binding (for the sero-
tonin and dopamine receptor system see 
[6]). In the present thesis, isoﬂurane gas 
was chosen as an agent because it facili-
tates greater control over duration (i.e. 
animals were kept in anesthesia for 3.5 
hrs in papers II and IV), and for not 
interacting severely with the OR system 
(paper IV) [42,58].  However, negative 
results obtained in the latter study (e.g. 
no signiﬁcant change in OR binding in 
main pain processing brain regions such 
as the cingulate cortex) could be caused 
by such interactions. In addition, in the 
present study anesthesia is not used only 
to constrain the animal during scanning, 
but is also used so that the animals do not 
consciously experience pain. To achieve 
this, isoﬂurane must interact with the 
supraspinal pain processing network. 
The signiﬁcance of these interactions 
is not fully understood, but can not be 
avoided due to ethical regulations.         
 Radiotracers. PET is the state of 
the art imaging modality for qualitative 
and quantitative assessment of recep-
tor systems in vivo, and requires highly 
selective radiotracers for targeting par-
ticular receptors and their subclasses. 
The development of such speciﬁc 
radiolabeled compounds is an ongoing 
challenge in the ﬁeld of radiopharma-
ceutical chemistry, and while paper III 
describes the development and evalua-
tion of a novel μ- and κ-OR-selective 
tracer, [11C]PEO, paper IV demonstrates 
its usefulness by measuring changes in 
opioid neurotransmission following a 
noxious stimulus. Despite binding to 
two subclasses of the ORs, the observed 
signal mainly reﬂects μ-binding due to 
the relative high abundance of μ-ORs 
(41 %) compared to κ-ORs (9%) in the 
rat brain [26]. However, in the human 
brain, κ-sites comprise 37 % of the total 
number of OR compared to 29 % for the 
μ-OR. Speciﬁc studies of the κ-ORs are 
also of interest due to their function in 
analgesia and dysphoria [16]. However, 
rats are not appropriate as study subjects 
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because of the low κ-ORs density. With 
the [11C]GR103545 tracer available, it 
would be natural to study the κ-OR 
function in human in relation to pain 
perception and processing. Further, the 
agonistic/antagonistic properties of a 
PET tracer are important for data inter-
pretation as agonists bind preferably to 
receptors in a high-afﬁnity state, while 
antagonists bind to both high- and low-
afﬁnity states. The results obtained in the 
agonist PEO-PET study will therefore 
represent changes in binding to μ-ORs 
in a high-afﬁnity state, which is believed 
to correlate to the state of endogenous 
OP binding.
 Quantiﬁcation. A PET receptor 
ligand can exist in various functional 
compartments in tissue; free ligand in 
tissue, non-speciﬁcally and speciﬁcally 
bound ligand. To estimate the latter com-
partment, a reference tissue method was 
used in order to calculate BPND, a mea-
surement of OR receptors concentra-
tion. The observed increase in BPND can 
be interpreted as reduced endogenous 
OP release or an increase in the con-
centration of available OR sites (Bmax) 
or increased receptor afﬁnity (1/KD) 
or a combination of all three. Further 
interpretation can not be obtained with 
the employed modality, but comple-
mentary technologies such as real-time 
polymerase chain reaction (RT-PCR) 
and immunohistochemistry should be 
applied in order to explore this in more 
detail. The present study only shows 
that the observed binding of PET tracer 
represents a state of the supraspinal OR 
system which is associated with spinal 
LTP.  
MULTI-MODALITY 
CO-REGISTRATION AND SPATIAL 
NORMALIZATION
 PET imaging reﬂects function and 
not primarily structure, and therefore, 
reveals few landmarks in the brain and 
skull. Hence, complementary imaging 
modalities and brain atlases are often 
used as spatial references. Comparisons 
of image data require co-registration or 
spatial normalization or both, either by 
manual or automatic procedures. The 
latter method excludes user-dependency, 
but involves complex algorithms which 
depend on a degree of mutual informa-
tion in the different data sets. Through-
out this project, automatic intra-subject 
alignment and spatial normalization 
were performed in SPM5. Depending 
on the available imaging modality, our 
ultimate aim was to register PET data to 
atlas space on the basis of the landmarks 
identiﬁable in the various image data. 
This registration performed in Atlas3D 
can currently only be made manually. 
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Hence, the registration procedure here 
presented is not fully-automatic. In addi-
tion, all registrations are based on linear 
transformation which might introduce 
local alignment errors due to inter-sub-
ject variations in rodent brain shape and 
size. Non-linear warping is complex and 
demanding, and results in deformation 
of data. For the low structural contrast 
image data presented in this thesis, lin-
ear registration has been sufﬁcient in 
order to obtain a valid localization.
LTP AND HYPERALGESIA
 In papers II and IV the focus has 
been on induction of LTP at C-ﬁbre syn-
apses, i.e. C-ﬁbre LTP, applying electri-
cal stimulation at 1.5 x C-ﬁbre thresh-
old. These observations do not include 
Aδ responses which are activated with 
lower test stimulus intensity. The mea-
sured C-ﬁbre threshold in paper IV is 
deﬁned as the lowest threshold for ﬁr-
ing of the second order spinal neurons 
in the superﬁcial laminae of the spinal 
cord. Many of these neurons project to 
supraspinal sites, and hence, the spi-
nal LTP measured in laminae I-III in 
the present studies may be important 
for the activity in the ascending pain 
pathways.  
 LTP induced by electrical con-
ditioning is often used to study mech-
anisms underlying long-lasting pain 
states. Moreover, Zhang and colleagues 
[61] have demonstrated that spinal 
C-ﬁbre LTP is also induced by acute 
nerve injury, such as cutting and crush-
ing of the sciatic nerve, which is known 
to produce a long-lasting neuropathic 
pain. In addition, a link between elec-
trical HFS conditioning of nociceptive 
afferents and enhanced pain perception 
has also been demonstrated in humans 
[20].       
 Previous studies have shown that 
the expression of spinal LTP is more pro-
nounced when the connection between 
the brain and recording site in the spinal 
cord is eliminated [11,55], i.e. when the 
synaptic activity is not modulated by 
the descending network. Therefore, it is 
tempting to speculate that the increased 
C-ﬁbre response and the reduced C-ﬁbre 
threshold observed in our studies, which 
also may be linked to hyperalgesia and 
allodynia, may be supported by a reduced 
descending inhibition. The correlation 
between hyperalgesia and spinal LTP is 
further strengthened by behavior ani-
mal studies which show a long-lasting 
reduction of paw withdrawal latency 
after induction of spinal LTP [62]. These 
evidences support the use of HFS con-
ditioning as a valid model for studying 
central sensitization. However, whether 
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this observed hypersensitivity is caused 
by a local spinal increase in synaptic 
efﬁcacy or changed supraspinal process-
ing remains to be investigated. 
THE OPIOID RECEPTOR SYSTEM
 The OR-selective radioligands 
presented in this project facilitate inves-
tigations of the functional role of opioid 
neurotransmission in the CNS. OPs are 
key neurotransmitters involved in pain 
modulation, and activated ORs mainly 
inhibit nociceptive transmission, which 
might explain the role of ORs as an 
analgesic. The antinociceptive effect is 
regulated by changes in the amount of 
endogenous OP release or OR availabil-
ity or receptor afﬁnity or a combination 
of all three. A reduced neurotransmis-
sion, as seen in paper IV, indicates a 
dysfunction in this inhibitory network, 
and hence a reduced antinociception 
(i.e. pronociception). Whether this dys-
function supports the maintenance of 
spinal LTP in the spinal cord remains 
to be investigated. However, the study 
reveals a signiﬁcant correlation between 
supraspinal opioid neurotransmission 
and hypersensitivity in the spinal cord. 
Such knowledge is important for under-
standing how chronic pain develops and 
for obtaining an optimal treatment for 
patients suffering from chronic pain.
FUNCTIONAL CHANGES IN 
SUPRASPINAL NOCICEPTIVE 
PROCESSING   
 Amygdala was the sole brain 
region which showed functional changes 
following noxious conditioning in both 
studies (papers II and IV). Increased 
neuronal activity (hypermetabolism) 
was observed in the FDG-PET study, 
while a reduction in opioid neurotrans-
mission was detected in the opioid PET 
study. Amygdala encompasses 13 nuclei 
and subnuclei [47], all with different 
structural and functional signature. In 
the present thesis, amygdala is referred 
to as a homogenous structure due to the 
spatial resolution provided by the PET 
modality. As part of the limbic system, 
amygdala plays a key role in memory 
formation and learning, emotional evalu-
ation of sensory stimuli, and in affective 
disorders such as anxiety and depres-
sion. Recent evidences, including results 
from in vivo imaging studies, indicate 
amygdala as an important contributor to 
pain and its emotional component (for 
review see [31]). Particularly, a recipro-
cal relationship exists between persistent 
pain and negative affective states such 
as fear, anxiety, and depression. Koepp 
and colleagues [21] have demonstrated 
a correlation between endogenous opi-
oid release and the regulation of posi-
tive emotions in humans. In addition, 
Trine Hjørnevik 31
Discussion
amygdala is also critically involved in 
pain modulation, including both pain 
enhancement and pain reduction. Anti-
nociception through the descending 
inhibitory network has been shown to be 
activated either through stressors (e.g. 
fear) or by introduction by exogenous 
opioids [33,34]. Amygdala is known to 
exploit a high degree of plasticity, which 
correlates to the functional changes seen 
in the present work. Our ﬁndings support 
the role of amygdala both in affective-
emotional response to noxious stimuli 
and in pain modulation.  
 In addition to amygdala, reduced 
opioid neurotransmission was also 
observed in other limbic structures 
such as the hippocampus, Acb, CPu, 
and hypothalamus. A painful experi-
ence is known to contain both sensory 
and affective dimensions, where the lat-
ter encompasses feelings of unpleas-
antness and emotions associated with 
future implications (for review see [39]). 
Motivational, emotional, and affective 
responses are processed in the limbic 
network, and particularly the hippocam-
pus plays a key role in the formation of 
so-called “pain memory” where noci-
ceptive stimuli leaves memory tracks 
in the CNS in order to prevent, prepare, 
and protect the organism in the future. 
Paper IV reveals functional changes in 
the affective component of pain, which 
most likely also inﬂuence the adapta-
tions seen in the brain regions involved 
in pain modulation.        
 As the main aim of this thesis 
was to investigate possible mechanism 
underlying the development of persis-
tent pain, the most interesting ﬁnding 
was a possible dysfunction in the pain 
modulatory network. This hypothesis 
is based on the observed metabolic 
changes in amygdala PAG, RVM, and 
DLTP, regions all involved in descending 
modulation (see Fig. 1 in Introduction). 
In addition, reduced opioid neurotrans-
mission was seen in the amygdala. The 
activity in the supraspinal pain process-
ing network is closely linked to the ﬁring 
properties of the second order neurons in 
the dorsal horn of the spinal cord, which 
transmits the nociceptive information 
through ascending pathways. 
 The spinal neurotransmission is 
modulated by descending pathways, 
either directly or by interneurons in the 
dorsal horn. A dysfunction in these mod-
ulating mechanisms may affect the sen-
sitivity in the neurotransmission at the 
spinal level. We suggest that the long-
lasting increase in spinal excitability 
observed in this study may be supported 
by a dysfunction in the descending pain 
modulatory network. Hence, this dys-
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in central sensitization such as hyperal-
gesia and allodynia.         
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CONCLUSIONS AND FUTURE PROSPECTS
Small animal PET is suitable for measuring functional changes in the rat  
brain. In particular, PET is superior for in vivo qualitative and quantitative 
investigations of receptor systems using highly selective radioligands. 
Digital 3-D atlas systems enhance interpretation of the signals seen in  
PET and MRI data with low structural contrast.
Advancements in radiopharmaceutical chemistry might contribute to an  
enhanced understanding of the functional role of the endogenous opioid 
receptors, e.g. to study speciﬁc κ-OR mechanisms and extending selec-
tive tracer studies to a clinical level.   
Induction of spinal LTP by electrical noxious conditioning results in  
supraspinal functional adaptations. Changes in neuronal activity and 
opioid neurotransmission occur in brain regions involved in pain modu-
lation. We suggest that these ﬁndings indicate an insufﬁcient inhibition 
in the descending pain modulatory network, which might cause states of 
abnormal pain sensitivity such as hyperalgesia. The following ﬁndings 
support this theory:
Induction of spinal LTP by HFS results in:
Increased C-ﬁbre response and reduced C-ﬁbre threshold1. 
Long-lasting metabolic adaptations in brain regions involved in 2. 
pain modulation
Reduced opioid neurotransmission in regions involved in pain 3. 
memory and processing
The aim of this thesis was to contribute to a better understanding of how 
chronic pain develops. The ultimate goal is to expand this knowledge to 
human use and the clinic, where further knowledge enables us to target an 
improved treatment of patients with chronic pain.
Conclusions
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Tomographic neuroimaging techniques allow visualization of functionally and structurally speciﬁc signals in the mouse and rat brain.
The interpretation of the image data relies on accurate determination of anatomical location, which is frequently obstructed by the lack
of structural information in the data sets. Positron emission tomography (PET) generally yields images with low spatial resolution and
little structural contrast, and many experimental magnetic resonance imaging (MRI) paradigms give speciﬁc signal enhancements but
often limited anatomical information. Side-by-side comparison of image data with conventional atlas diagram is hampered by the 2-D
format of the atlases, and by the lack of an analytical environment for accumulation of data and integrative analyses. We here present
a method for reconstructing 3-D atlases from digital 2-D atlas diagrams, and exemplify 3-D atlas-based analysis of PET and MRI data.
The reconstruction procedure is based on two seminal mouse and brain atlases, but is applicable to any stereotaxic atlas. Currently,
30 mouse brain structures and 60 rat brain structures have been reconstructed. To exploit the 3-D atlas models, we have developed
a multi-platform atlas tool (available via The Rodent Workbench, http://rbwb.org) which allows combined visualization of experimental
image data within the 3-D atlas space together with 3-D viewing and user-deﬁned slicing of selected atlas structures. The tool presented
facilitates assignment of location and comparative analysis of signal location in tomographic images with low structural contrast.
Keywords: 3-D reconstruction, atlas, brain, imaging, magnetic resonance imaging, positron emission tomography, stereotaxic, visual-
ization
INTRODUCTION
Positron emission tomography (PET) and magnetic resonance imaging
(MRI) techniques are increasingly used for investigations of the mouse
and rat brain, in the context of numerous types of general brain mapping
or disease model investigations. PET imaging reﬂects function and not
primarily structure, and therefore, reveals few landmarks in the brain or
skull. MRI imaging shows a variable degree of structural detail, depend-
ing on the speciﬁcations of the instrument and the imaging protocols. A
common challenge is therefore to assign locations to the data collected
with use of available brain atlases.
PET and MRI techniques produce three-dimensional (3-D) volume
(tomographic) data, whereas standard brain atlases have until recently
been available only in a two-dimensional (2-D) format. The established
and most commonly used atlases of the mouse and rat brain (Paxinos and
Franklin, 2001; Paxinos andWatson, 1998, 2005; Swanson, 2004) provide
series of sections, cut at speciﬁed angles, with external surfaces and
internal boundaries of areas and nuclei indicated, and names assigned to
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the delineated structures. Use of such atlases for neuroimaging studies
are hampered by the 2-D format as well as a lack of an analytical
environment for comparison and integration of atlas and image data.
Recently, atlases with 3-D representations of major brain structures
have been developed for the mouse (Boline et al., 2006; Chan et al.,
2007; Gustafson et al., 2004; Lein et al., 2007; MacKenzie-Graham et al.,
2004). Both the 3-D mouse brain atlas of the Biomedical Informatics
Research Network, BIRN (Boline et al., 2006), and the 3-D surgical mouse
atlas developed at the University of Toronto (Chan et al., 2007) support
import of experimental data (e.g., TIFF and Analyze Image format), which
can either be visualized as orthogonal slices in a separate window or in
the 3-D viewer. Furthermore, the BIRN atlas facilitates alignment of the
experimental data with the atlas, with a set of predeﬁned transformation
parameters (i.e., 180 degrees rotation, swapping, and mirroring). As
concerns 3-D rat brain atlases, several efforts are under development
(see e.g., Gustafson et al., 2004, 2007), and a recently deployed
neuroanatomical afﬁliation visualization-interface system demonstrates
parts of the rat brain stem in 3-D (Palombi et al., 2006), but there is to
our knowledge currently no comprehensive rat brain atlas available.
To further facilitate the task of establishing a spatial mapping between
neuroimaging data and atlas space for the mouse and rat brain, we have
established a pipeline for 3-D reconstruction of structures from two of
the seminal high-resolution standard atlases (Paxinos and Franklin, 2001;
Paxinos and Watson, 2005) including the stereotaxic space provided by
the atlases. These particular rodent atlases are widely used and share a
common nomenclature for bothmouse and rat. The present versions of the
3-D reconstructed atlases include 30 structures for the mouse brain and
1
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Figure 1. The stepwise 3-D atlas reconstruction procedure. (A) A coronal rat brain atlas diagram (reproduced from Paxinos andWatson, 2005, with permission)
with the stereotaxic grid, section number, structure labeling and the distance from bregma indicated. (B) The same diagram imported to Illustrator, where regions
of interest (ROIs) are selected and assigned a color code. (C) Image of the Amira GUI showing segmented ROIs. (D) Selected 3-D reconstructed structures
visualized in the m3d tool. (E) The same reconstruction as shown in (C) coronally sub-divided using the m3d slicing module. (F) Customized atlas diagram,
corresponding to (A), exported from m3d. A separate module in m3d is used to render the sub-divided surfaces as solid objects. ic, internal capsule; Rt, reticular
thalamic nucleus; VPM, ventral posterolateral thalamic nucleus; VPL, ventral posteromedial thalamic nucleus; cc, corpus callosum; Po, posterior thalamic nucleus.
60 structures for the rat brain. We have, furthermore, developed a multi-
platform tool that allows sharing of the reconstructed atlas framework,
surface modeling and rotation of selected structures, slicing at any chosen
angle, and the possibility to add newstructures to the framework according
to the requirements of a given study. The tool allows import of PET andMRI
data to facilitate comparison with the atlas and warping of experimental
image data into atlas space. The approach taken uses linear registration,
with the possibility to scale, rotate, and position the imported data, either
globally, using the whole brain as template, or locally, using smaller parts
of the brain as template. Here we demonstrate the use of this tool as a
dynamic and analytical environment for assigning location to image data
and discuss advantages of the approach taken as well as some of the
remaining challenges.
MATERIALS AND METHODS
Structures from two atlases, “The Rat Brain in Stereotaxic Coordinates”
by Paxinos and Watson (2005) and “The Mouse Brain in Stereotaxic Coor-
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Figure 2. Examples of rat brain regions included in the 3-D rat brain atlas. (A–H) Atlas representations of four major brain regions visualized as solid, color
coded 3-D surfaces within the transparent outer surface of the brain, and as corresponding 2-D coronal slices, obtained from anteroposterior levels indicated
by arrows. (A, B) 16 selected cerebrocortical brain regions. (C, D) Major regions of the basal ganglia. (E, F) Hippocampus and entorhinal cortex. (G, H) Selected
sub-regions of the thalamus. In (G) thalamus (th) is made transparent in order to visualize the underlying sub-regions. Cg2, cingulate cortex area 2; Cg1,
cingulate cortex area 1; S1, primary somatosensory cortex; S1HL, hindlimb region; S1FL, forelimb region; S1DZ, dysgranular zone; S1ULp, upper lip region; S2,
secondary somatosensory cortex; DI/GI, insular cortex; Fr3, frontal cortex, area 3; S1J, jaw region; S1Tr, trunk region; S1BF, barrel ﬁeld; V2L, secondary visual
cortex, lateral area; V2M, secondary visual cortex, medial area; V1, primary visual cortex; Lent, lateral entorhinal cortex; Acb, accumbens nucleus; CPu, caudate
putamen; EGP, external globus pallidus; IGP, internal globus pallidus; STh, subthalamic nucleus; SNR, substantia nigra; DG, dentate gyrus; CA2/CA3, ﬁeld CA2
and CA3 of the hippocampus; CA1, ﬁeld CA1 of the hippocampus; LEnt, lateral entorhinal cortex; MEnt, medial entorhinal cortex; th, thalamus, whole region;
sub, submedius thalamic nucleus; Po, posterior thalamic nucleus; VPM, ventral posterolateral thalamic nucleus; VPL, ventral posteromedial thalamic nucleus;
Rt, reticular thalamic nucleus; PF, parafasicular thalamic nucleus.
dinates” by Paxinos and Franklin (2001) were 3-D reconstructed. The
diagrams in Paxinos and Watson (2005) were derived from coronal sec-
tions spaced at intervals of 120m, all collected from a single Wistar rat
brain. The diagrams in Paxinos and Franklin (2001) were obtained from a
sample of 26 adult C57BL/J6 mice. Both atlases use the same stereotaxic
coordinate system (Paxinos and Watson, 1982), structure nomenclature
and abbreviations. The reconstruction procedure is here exempliﬁed with
use of the Paxinos and Watson (2005) atlas, but may be applied to any
stereotaxic atlas providing digital drawings. The practical application of
the reconstructed 3-D rat brain atlas is exempliﬁed on basis of a set of
MRI and PET data.
3-D atlas reconstruction and visualization
The coronal atlas of Paxinos and Watson (2005) provides digital dia-
grams (EPS format; Figure 1A) containing separate information layers
(i.e., stereotaxic coordinate grid, structure names, and boundary lines).
All diagrams were organized in separate layers and aligned to the stereo-
taxic grid of the atlas using Adobe Illustrator CS2 (Adobe Systems Inc.,
San Jose, CA). Regions of interest (ROIs, deﬁned by closed boundary lines
in the atlas) were segmented in relevant diagrams by assigning a speciﬁc
color (Figure 1B). Occasionally, structures lacked unequivocally deﬁned
or closed boundaries, and contour lines were closed arbitrarily after fol-
lowing a set of predeﬁned rules. Each segmented layer was exported
separately as an image (TIFF) ﬁle to Amira 4.0 (Mercury Computer Systems
Inc., Chelmsford, MA) for 3-D reconstruction. Since the export function in
Illustrator is based on what is visible in the ﬁgure, all other layers and
sub-layers were hidden. All exported images were enclosed by a stan-
dard invisible (white) rectangular frame, representing the stereotaxic X,Y
space for each diagram, to ensure identical dimension and positioning of
objects. Anterioposterior positions (Z-values) were deﬁned by the bregma
values given in the atlas diagrams. These values were entered upon load-
ing stacks of image ﬁles to Amira, resulting in a 3-D atlas reconstruction
aligned according to the stereotaxic framework of the atlas. Image col-
ormaps (RGBA-tupels) were converted to intensity values represented as
gray scale images, and voxels were assigned to the different structures
using the “LabelVoxel” tool in Amira, employing thresholding algorithms
(Figure 1C). Surfaces were rendered using the Amira SurfaceGen tool
and exported as VRML (Virtual Reality Modeling Language) ﬁles. A custom
Java3D visualization tool (m3d) was developed to import and visualize the
VRML atlas structures (Figures 1D, and 2) as well as tomographic image
data (PET or MRI) in NIfTI (Neuroimaging Informatics Technology Initiative,
http://nifti.nimh.nih.gov) ﬁle format. The volumetric image data were visu-
alized using texture mapping with transparency and thresholding applied
to Texture3D Java3D class, and displayed in m3d together with the 3-
D atlas structures. In addition, 2-D user-deﬁned slices, prepared at any
angle and orientation, of both the atlas (performed by ModelClip Java3D
3
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Figure 3. Customized atlas diagrams. Series of customized, color coded coronal (B, F), horizontal (C, G), and sagittal (D, H) atlas diagrams, generated using the
slicing and ﬁlling module in the atlas tool. Blue, red, and green bounding boxes in (A, E) indicate the levels from which the respective slices were obtained. (A–D)
Standard orientation of atlas slices, oriented perpendicularly to axes of the stereotaxic coordinate system. (E–H) Example of atlas slices cut at non-standard
angles, tilted 5 degrees from the planes used in (B–D). Black arrow heads indicate examples of structural differences between the corresponding diagram pairs,
emphasizing the importance of having atlas diagrams with similar orientation as experimental slices. hy, hypothalamus, whole region; ic, internal capsule; cc,
corpus callosum; CA1, ﬁeld CA1 of the hippocampus; CA2/CA3, ﬁeld CA2 and CA3 of the hippocampus; DG, dentate gyrus; cg, cingulum; Po, posterior thalamic
nucleus; Rt, reticular thalamic nucleus; VPL, ventral posteromedial thalamic nucleus; VPM, ventral posterolateral thalamic nucleus; AHi, amygdalohippocampal
area; ml, medial lemniscus; CPu, caudate putamen; PF, parafasicular thalamic nucleus; STh, subthalamic nucleus; ML, medial mammillary nucleus.
class extended by a cutting and contour-ﬁlling algorithm; Figures 2 and
3) and the image data were generated.
Image import and co-registration
Co-registration of experimental image data to atlas space can be achieved
in several ways. The present version of the m3d program allows afﬁne
transformations that are implemented with use of a transformation tool
interface for deﬁning scaling, rotation, and translation. As exempliﬁed
below, co-registration is based on recognizable brain or skull landmarks,
and different strategies may be employed depending on the nature of
the image data. The precision of co-registration critically depends on the
precisionwithwhich anatomical landmarksmay be detected, which in turn
also depends on voxel size and structural contrast (see also Discussion).
Size and shape differences that may occur due to individual variation
or by extraction of the brain from its enclosed position in the skull, can
be adjusted by non-linear transformation (not included in the present
software), or by limiting the co-registration to smaller ROIs.
Animal experiments
Animal procedures were approved by institutional animal welfare com-
mittees at the University of Oslo or Massachusetts General Hospital, and
were in compliance with National Institutes of Health guidelines for the use
and care of laboratory animals. During all experiments body temperature
was kept constant by the means of feedback regulated heating pads. Eye
ointment was applied in order to prevent dehydration of the cornea.
In vivo pathway tracing with Mn 2+-enhanced MRI. MR images were
obtained at the Massachusetts General Hospital NMR-Center using a
3 Tesla Trio whole body human scanner (Siemens Medical Solutions,
Iselin, NJ). Adult male Sprague–Dawley (SD) rats (Taconic farms, German-
town, NY) were anesthetized with urethane (Abbott, Chicago, IL; 1.2 g/kg
i.p., with 10% supplements during surgery as needed). This provided
stable anesthesia for the entire imaging session (see also Field et al.,
1993). Animals were monitored by pulse oximetry, and body tempera-
ture was maintained at 37◦C by a water-circulating heating pad (Gaymar
T/Pump; Gaymar Industries, Orchard Park, NY). The T1 contrast agent
manganese (Mn2+) was applied as outlined in Leergaard et al. (2003).
Brieﬂy, animal heads were immobilized in a stereotaxic frame, a small
opening was made in the skull and dura overlying the SI cortex, and
∼10 nl of an aqueous solution of 2.0 M manganese chloride (MnCl2; ICN
Biomedicals Inc., Aurora, OH) was slowly injected 1.0mm below the pial
surface through a glass pipette mounted on a 1.0l Hamilton syringe
placed in a microinjection unit (Kopf 5001, Kopf Instruments, Tujunga,
CA). Locations of injection sites were stereotaxically deﬁned according to
published topographical maps (Chapin and Lin, 1984). MR images were
obtained using the (human) body RF coil for excitation, and a custommade
loop surface receiver coil. T1 weighted volumetric images were obtained
using a 3-D FLASH sequence with TR/TE/ﬂipangle = 44ms/13.37ms/40
degrees. Images were obtained with 195m isotropic voxels, ﬁeld of
view = 50× 50× 50mm3, matrix = 256× 256× 256, with a scan time
of 48minutes and 4 seconds. The animals were scanned continuously,
starting within an hour after the MnCl2 injection, and continuing up to
8–9 hours after injection. At the end of the imaging experiments, animals
were euthanized with an overdose of sodium pentobarbital (200mg/kg).
To optimize visualization of the brain surface, the soft tissue
surrounding the brain was stripped away from the raw MR images using
PMOD software (PMOD Technologies Ltd., Zurich, Switzerland). The
trimmed MR images were imported to the 3-D atlas tool (Figures 4D
and 4G) and globally ﬁtted to atlas space using afﬁne transformations,
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Figure 4. MRI and 3-D atlas based localization of MnCl2 injection sites in the cerebral cortex. (A) Color coded drawing of major body representations in
the primary somatosensory cortex (SI), modiﬁed from Welker (1971), with permission. (B) 3-D reconstructed atlas representation of the brain surface with SI
regions indicated in corresponding colors. (C–E) and (F–H) show two different examples, in which MnCl2 was stereotaxically aimed at the forelimb or hindlimb
representations of SI, respectively. (C, F) Raw T1-weighted MRI images acquired 9 hours after focal application of MnCl2. At the point of injection a central zone of
low signal intensity is visible, surrounded by a halo of bright signal enhancement. (D, G) 3-D reconstructed MRI volume registered to atlas space, showing Mn2+
signal enhancement surrounding the injection sites (arrows). (E, H) The same images combined with atlas reconstructions of relevant SI body representations.
Comparison of injection site locations with the atlas surface reconstructions revealed that one injection is centered on the dysgranular zone lateral to the SI
forelimb representation, while the other injection is centered on the SI hindlimb representation. Bar, 1 mm.
based on measurements of multiple anatomical landmarks recognizable
in the images (brain surface and midline, the genu and splenium of
the corpus callosum, the decussation of the anterior commisure, the
ventricular system, the boundary between the cortical gray matter and
underlying white substance, the external boundaries of the hippocampus,
the caudate putamen complex, the optic chiasm, the substantia nigra
(intercalated between the cerebral peduncle and the medial lemnisc),
and the rostral boundary of the pontine nuclei). Because the in vivo
position of the cerebellum and of the ﬂaccid brain stem caudal of the
pons clearly differed from the atlas, these structures were disregarded in
the alignment procedure. For this dataset, the spatial displacement of the
different image landmarks with respect to corresponding atlas landmarks,
was measured to 164m± 23 SEM, (range of 11–446m), which is at
the level of the resolution of the image data (voxel size = 195m). The
size and location of the MnCl2 injections were analyzed by 3-D combined
visualization of the MR based representation of the brain surface and the
atlas representations of different cerebrocortical areas (Figures 4E and
4H). The position of Mn2+ signal enhancement within the thalamus was
analyzed by slicing the combined image and atlas volumes in 200m
thick slices using the m3d tool (Figures 5D, 5E, 5I, and 5J).
PET experiments. PET data were acquired at the Small Animal Imaging
Unit of the Center for Molecular Biology and Neuroscience, University
of Oslo, Norway, with use of a small animal PET scanner (microPET
Focus 120, Siemens Medical Solutions, Erlangen, Germany). Accompany-
ing computer tomography (CT) data were collected with a small animal CT
scanner (microCAT, Siemens Medical Solutions, Erlangen, Germany). The
microPET scanner provides high sensitivity (6.5%) and high spatial reso-
lution (<1.3mm; Kim et al., 2007). A multi-modality animal bed was used
to collect data with both the PET and CT scanner without re-positioning
the animal.
Three different kinds of PET-data were imported to the 3-D atlas tool:
individual dopamine D2/D3 receptor binding data acquired using [18F]-
fallypride, individual brain and glioma tumor glucose metabolism data
acquired using [18F]-ﬂuorodeoxyglucose (FDG), and statistical parametric
mapping (SPM) group data collected from a study of brain activity during
nociceptive conditioning using FDG.
Individual PET receptor binding data. SD rats (National Lab Animal Cen-
ter, Oslo, Norway)weighting 200–250 g,were anesthetized by inhalation of
isoﬂurane 2% (Abbott Laboratories, Illinois, USA). 20MBq [18F]-labeled fal-
lypride (Department of Chemistry, University of Oslo, Norway) was injected
intravenously, and the rats were scanned for 180minutes. Data were
collected in list mode and reconstructed using 3-D OSEM-MAP (Jinyi
and Leahy, 2000; Jinyi et al., 1998) (2 OSEM iterations, 18 MAP iter-
ations, β = 0.5, 128× 128× 95 matrix size, 0.87× 0.87× 0.80mm3
voxel size). Two image volumes were extracted from the acquired scans:
a sum image of the ﬁrst 5minutes of the scan reﬂecting tracer delivery
(“perfusion”) and a late scan sum image (60–180minutes) represent-
ing the D2/D3 receptor binding of [18F]-fallypride. Data were imported
and globally aligned to the atlas space in m3d on basis of the “perfu-
sion” image showing the external boundaries of the brain, as well as the
receptor binding image, showing a negative image of the brain surface
(Figures 6A–6D).
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Figure 5. Corticothalamic topographical organization revealed by MnCl2/MRI tracing and 3-D atlasing. Two cases are shown, case 1 (A–E), in which
MnCl2 was injected in the dysgranular zone adjacent to the SI forelimb representation (A), and case 2 (F–J), in which MnCl2 was injected in the hindlimb
representation of SI. (B, C and G, H) Raw coronal and sagittal T1-weighted MRI images obtained 9 hours after injection. (D, E and I, J) Corresponding images with
overlay of selected reconstructed atlas structures. (K, L) Superimposed, pseudocolored images (case 1, yellow; case 2, blue) with an overlay of atlas derived
boundary lines, demonstrating a somatotopical organization of the different signals within the Po and VPM. ic, internal capsule; Po, posterior thalamic nucleus;
VPM, ventral posterolateral thalamic nucleus; VPL, ventral posteromedial thalamic nucleus; Rt, reticular thalamic nucleus. Bar, 1 mm.
Individual FDG-PET and CT data. Inbred BDIX rats (body weight > 220 g;
Harlan Olac Ltd. Bicester, UK) were used. The animals were anesthetized
by subcutaneous injection (2ml/kg) of a mixture of equal volumes of
Hypnorm (fentanyl citrate 5mg/mL, Janssen L.P., High Wycombe, UK) and
Dormicum (midazolam 5mg/mL, Hoffmann-La Roche Ltd., Basel, Switzer-
land). Fifteen days prior to the FDG-PET scan, 50.000 glioma cells (BT4Ce
gliomasarcoma cell line) were inoculated. The inoculation was performed
with the animal ﬁxed in a stereotaxic frame and injected with a 30G blunt
needle through a 1.0mm burrhole. FDG (GE Healthcare AS, Oslo, Norway)
was injected intravenously and the animals were scanned for 60minutes.
Attenuation correction was obtained by a 10minute transmission scan
with a 68Ge point source prior to injection. Data were collected in list
mode and reconstructed using 3-DOSEM-MAP (2OSEM iterations, 18MAP
iterations, β = 0.5, 128× 128× 95matrix size, 0.87× 0.87× 0.80mm3
voxel size). The animals were then transferred to the CT scanner utilizing
the multi-modality bed ensuring the same position of the head. CT images
were acquired using the same settings for all studies (80 kVp, 0.5mA,
400ms, 360 degrees rotation). Data were reconstructed using Feldkamp
reconstruction (512× 512× 512 matrix size, 0.1× 0.1× 0.1mm3 voxel
size). The FDG-PET and CT data were co-registered in PMOD, re-slicing
the resulting PET image to match the matrix and resolution of the CT
volume. The CT data were imported into m3d and linearly ﬁtted to atlas
stereotaxic space on basis of the readily identiﬁable bregma and interaural
line (Figures 6I and 6J). The same transformation parameters as for the
CT data were used to ﬁt the FDG-PET data set into exactly the same atlas
space (Figure 6L).
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Figure 6. (Continued ).
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SPM group results. Twenty female SD (National Lab Animal Center, Oslo,
Norway) rats weighing 200–250 g, were adapted for minimum 10 days to
the environment and given food and water ad libitum. For the experiments,
the animalswere anesthetized by inhalation of 2% isoﬂurane (Abbott Labo-
ratories, Illinois, USA) and divided into two groups; nociceptive stimulation
condition (n=10) and sham (n=10). In addition, all animals were scanned
at baseline. FDG (20–25MBq; GE Healthcare AS, Oslo, Norway) was
injected through the tail vein and all animals were scanned for 60minutes.
Attenuation correction was obtained by a 10minutes transmission scan
with a 68Ge point source prior to FDG injection. Data were collected
in list mode and dynamically reconstructed using 3-D OSEM-MAP (2
OSEM iterations, 18 MAP iterations, β= 0.1, 128× 128× 95 matrix size,
0.87× 0.87× 0.80mm3 voxel size). Statistical comparisons (paired t-test
stimulation-baseline) between the two groups were performed with SPM5
(Statistical Parametric Mapping, http://ﬁl.ion.ucl.ac.uk/spm) after intra-
subject co-registration and spatial normalization to a MRI template ﬁtted
to Paxinos and Watson atlas space (Schweinhardt et al., 2003; Figure
6Q). Signiﬁcance was accepted at the 5% level. Localization of statistical
signiﬁcant activity was deﬁned by the use of the 3-D atlas model. The MRI
template was aligned with the atlas model in m3d (Figures 6R and 6S)
by the means of identiﬁable anatomical landmarks (outer boundaries of
the brain surface, gray and white matter contrast, genu and splenium of
the corpus callosum, outer boundaries of the hippocampus and caudate
putamen, and the ventricle system). Since spatial normalization between
the PET data and the MRI template was already performed in SPM5, the
same linear transformation obtained from the alignment could be applied
to the PET data (Figure 6T).
RESULTS
We have developed a procedure for 3-D reconstruction of a series of
2-D diagrams from conventional brain atlases. The 3-D reconstructed
atlases are displayed and utilized in a multi-platform tool (m3d), prepared
to include experimental data of different formats (i.e., JPEG, PNG, VRML,
and NIfTI). The focus of the present report is to exemplify how a relatively
straightforward atlas approach may be useful for the neuroanatomical
analysis in the context of import of whole brain MRI and PET data.
The 3-D rat brain atlas currently includes 60 structures, while 30
structures have been incorporated in the 3-D mouse brain atlas. The
structures included are the outer boundaries of the brain and areas, zones
and nuclei of the cerebral cortex, hippocampus, basal ganglia, thalamus,
amygdala, as well as major ﬁber tracts (Figures 2A, 2C, 2E, and 2G).
The m3d atlas visualization tool allows interactive inspection of selected
3-D reconstructed structures as well as user-deﬁned slicing to create
customized 2-D atlas diagrams at any position and angle of orientation.
This feature is particularly suitable for comparison with experimental data
cut at angles different from the standard coronal, sagittal, or horizontal
orientations used in printed brain atlases (Figures 3E–3H).
The current version of the m3d tool allows import of image data and
subsequent registration of images to atlas space by interactive scaling,
rotation, and translation on basis of recognizable landmarks. Depending
on the modality of the experimental data, the alignment can be performed
globally for the entire whole brain data set, using the outer boundaries of
the brain as a template, and/or locally for parts of the whole brain data set,
utilizing smaller readily identiﬁable landmarks in the brain. In addition, the
quality of the registration can be enhanced by a step-by-step alignment
of the atlas and image data with use of slicing at different locations and
angles. In m3d, co-registered image and atlas representations can be
co-visualized as 3-D objects and in 2-D custom deﬁned slices.
In the following, we exemplify the use of the 3-D atlas for assigning
location to MRI and PET image volumes.
MRI example
To illustrate the use of the 3-D atlas to assign location to discrete structural
signals observed with MRI, we here describe two experiments in which
high-resolution in vivo MnCl2/MRI pathway tracing (see e.g., Leergaard
et al., 2003; Pautler et al., 1998; Saleem et al., 2002) was used to visu-
alize speciﬁc corticothalamic connections, and 3-D atlasing was used to
assign location to tracer injection sites and observed signal enhance-
ment. To evaluate the position of injection sites and the corticothalamic
signal enhancement, the two MR image volumes were registered to atlas
space on basis of multiple recognizable anatomical landmarks and afﬁne
transformations.
In the two example experiments, MnCl2 was injected on basis of
stereotaxic coordinates, respectively aimed at the forelimb or hindlimb
representations of the primary somatosensory cortex (SI). When the ani-
malswere scanned∼9 hours after the injection, injection siteswere visible
in the T1-weighted images as bright regions, surrounding a core with low
signal intensity, presumably associated with high concentration of Mn2+
(Figures 4C and 4F; see also discussion in Leergaard et al., 2003). Mn2+
signal enhancement was observed at multiple cortical and sub-cortical
locations, as reported in Leergaard et al. (2003). Discrete Mn2+ signal
enhancement was observed in the internal capsule (ic) and at multiple
sites within the thalamus (Figures 5B, 5C, 5G, and 5H).
Co-visualization in m3d of the co-registered MR image volumes and
atlas reconstructions of SI body representations (Figures 4D–4H) demon-
strated that the injection site center in one example was located slightly
outside the targeted forelimb representation (Figure 4E), and in the other
example that the injection site center was located centrally in the hindlimb
representation (Figure 4F). Identical results were obtained with use of
manual measurements of the mediolateral and anterioposterior distances
from the injection site centers to the midline and the genu and splenium of
the corpus callosum in the MR images. The manual measurements were
converted to stereotaxic coordinates using the printed atlas of Paxinos and
Watson (2005), and compared to known functional maps of SI (Chapin and
Lin, 1984).
To evaluate the location of Mn2+ signal enhancement within the thala-
mus, series of contiguous 200m thick coronal and sagittal slices were
obtained from the combined atlas and MRI volume. Overlay images of
Figure 6. Alignment and localization of PET data. Example 1: (A–C) perfusion image of [18F]-fallypride image was used for alignment to 3-D atlas space.
Arrows indicating surface boundaries. (D) Receptor binding image co-registered with the 3-D atlas model. (E, F) [18F]-fallypride-PET coronal and sagittal images
showing high-uptake regions. (G, H) Coronal and sagittal atlas sections localizing the high-uptake PET signals to the basal ganglia. Example 2: (I, J) Bregma
and the interaural line in the CT volume. (K) CT volume aligned with the 3-D atlas model. (L) FDG-PET signal aligned with the 3-D atlas on the basis of the
same transformation matrix as for the CT volume. (M, N) Coronal and sagittal PET images showing high-uptake of FDG in the brain tumor. (O, P) Coronal and
sagittal atlas diagrams locating the brain tumor in the right thalamic region. Example 3: (Q) co-registered FDG-PET image (colors) and MRI template. (R, S) MRI
template aligned to the 3-D atlas space on the basis of deﬁned landmarks. *, midline; **, upper boundary of cc. (T) SPM result volume aligned with atlas space
using the transformation matrix obtained from the MRI alignment. (U, V) Coronal and sagittal SPM result images showing statistical signiﬁcant voxels (p < 0.05).
(W, X) Coronal and sagittal atlas diagrams locating the signiﬁcant signal to the rostral part of the amygdala. ic, internal capsule; Acb, accumbens nucleus; CPu,
caudate putamen; EGP, external globus pallidus; cc, corpus callosum; DG, dentate gyrus; CA2/CA3, ﬁeld CA2 and CA3 of the hippocampus; CA1, ﬁeld CA1 of the
hippocampus; th, thalamus, whole region; hi, hippocampal region; ec, external capsule; AHi, amygdalohippocampal area. Arrows indicate boundaries of regions
with increased PET signal. Bar, 1 mm.
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relevant atlas structures (thalamic sub-nuclei and the internal capsule)
and MR images allowed atlas based anatomical segmentation of the MR
images (Figure 5). Thus, aided by the atlas overlay, it was possible to
distinguish Mn2+ signal enhancement located in the internal capsule and
within the posterior complex thalamus (Po) and the ventral posterolateral
nucleus thalamus (VPL) in both examples. Combined analysis of the two
data sets further allowed assessment of topographical organization at a
ﬁner scale (Figures 5K and 5L). This analysis clearly demonstrated that
the discrete clusters of signal enhancement where primarily distributed
within the boundaries of Po and VPL (Figure 5K), with an inside-out rela-
tionship corresponding to the well known internal to external somatotopic
distribution of hindlimb and forelimb representations in these thalamic
sub-nuclei (Fabri and Burton, 1991). Signal enhancement was also seen
in the reticular thalamic nucleus (Figure 5K), presumably representing
pathways en route to the Po and VPL. Furthermore, in our ﬁrst exam-
ple (Figures 5B–5E) some signal enhancement was also observed in the
ventral posteromedial thalamic nucleus (VPM), known to hold represen-
tations of the face (Fabri and Burton, 1991). This ﬁnding is presumably
related to the location of the injection site center in the dysgranular zone
between the forelimb and face representations in SI. We conclude that the
present 3-D atlas approach provided an anatomical segmentation of the
observed signal enhancement sufﬁciently accurate to resolve ﬁner details
of the well-known topographical organization found within sub-nuclei of
the thalamus (see e.g., Deschenes et al., 1998; Fabri and Burton, 1991;
Price, 1995).
PET examples
To illustrate the use of the 3-D atlas to assign location to PET data (Figure
6), we have used three different sets of experimental data.
Individual PET receptor binding data. The [18F]-fallypride data set
represents the D2/D3-receptor binding in the brain. The receptor bind-
ing image itself contains little anatomical information and could not be
aligned to atlas space (Figures 6E and 6F). “Perfusion” images of early
frames representing the initial hematogeneous tracer distribution were
used (Figures 6A–6C) to facilitate alignment, since these data show the
external contours of the cerebrum and cerebellum, as well to a certain
degree the outlining of the basal ganglia using different levels of voxel
intensity scaling. The same transformation parameters were then used
to ﬁt the receptor binding image into the atlas space in m3d (Figure
6D). Visualization of the receptor binding showed the highest density of
dopamine D2/D3 receptors to be present in the basal ganglia (Figures 6G
and 6H). Only a course alignment of the experimental data with the atlas
was possible due to limited structural information. A further judgment of
details of distribution was not deemed possible with the present approach.
Individual FDG-PET and CT data. FDG is a glucose analog and FDG-PET
images represent the rate of glucose metabolism of the cells. Cancer cells
mostly utilize more glucose than healthy tissue and tumors can therefore
be located as regions with high uptake of FDG in a PET scan (Figures 6M
and 6N). To be able to decide the size, extent, and location of the brain
tumor, the co-registered CT image was imported and aligned to the 3-D
atlas space in m3d using the location of bregma and the interaural line
which could be readily deﬁned in the CT volume (Figures 6I and 6J). The
inoculation site for the glioma cells is shown in Figure 6 K. The same
transformation matrix was applied to the FDG-PET volume in order to ﬁt
the data to atlas space (Figure 6L). The increased FDG signal deﬁning
the brain tumor was located in the right thalamic region. The quality
of the alignment procedure was in this case considerably enhanced by
utilizing CT as a complementary imaging modality. The readily identiﬁable
bregma and the interaural line provided concrete landmarks which could
be aligned in 3-D atlas space. Inaccuracies can occur due to inter-subject
variations in brain shape and size, and due to the fusion procedure of the
PET and CT data prior to import into m3d.
SPM group results. SPM delivers a result volume (cluster of voxels) at a
speciﬁed statistical signiﬁcance value (Figures 6U and 6V). This paramet-
ric volume was already ﬁtted to the space of a deﬁned anatomic template.
The MRI template was imported and aligned to the 3-D atlas space in
m3d by the aim of well-deﬁned landmarks, i.e., white matter and the
contours of the brain (Figures 6R and 6S) The same parameters were
applied to the signiﬁcant parametric volume in order to ﬁt the data to the
atlas space (Figure 6T). The nociceptive conditioning is an aversive and
stressful event, in which amygdala play a crucial role (Sah et al., 2003).
After alignment, a signiﬁcant effect of nociceptive conditioning could be
localized to the rostral volume of the amygdala (Figures 6W and 6X). The
alignment of the MRI template to the 3-D atlas space was performed using
a best-ﬁt approach based on large brain regions. Due to variations in the
rat brain shape and size, a perfect ﬁt is difﬁcult to obtain. If focusing on
speciﬁc areas within the brain, the transformation parameters might be
altered using smaller local sub-regions as alignment landmarks. However,
the resolution of microPET and averaging over several individuals has an
inherent inaccuracy limiting the detailed localization and separation of
smaller effects to speciﬁc, smaller sub-nuclei of any rat or even mouse
brain structure. Once the MRI-template has been sufﬁciently aligned to
a 3-D atlas, the same transformation routine and result reading can be
established for all data processed with statistical parametric mapping.
The 3-D atlas makes the data processing and interpretation less observer
dependent. As shown in Figures 6T–6X, the 3-D atlas ensures a sufﬁ-
ciently precise allocation of a statistical signiﬁcant result to a brain area
in relation to neighboring structures.
DISCUSSION
We present a multi-platform tool that provides a new dynamic and analyti-
cal environment for comparing experimental image data to a seminal atlas
reconstructed in 3-D. Our 3-D reconstruction procedurewas applied to two
commonly used rodent brain atlases, but could be applied to other atlases
as long as they provide diagrams from sections with limited distortions,
mapped into a stereotaxic coordinate system.We further demonstrate how
the atlas tool can be used to align 3-D data of different origin (PET, PET/CT,
and MRI) to the same atlas space, facilitating analysis of localization in
the experimental data.
In the example analyses provided, variable amounts of informationwas
available to assist the user with the registration of the experimental data to
the 3-D atlas space. Themost limited structural informationwas present in
the receptor binding PET data. The global registration performed for these
data, based on the outer contours of the brain visible in the early frames
recorded, was nevertheless sufﬁcient to identify the caudate-putamen
as the region containing the highest [18F]-fallypride receptor binding, in
agreement with legacy data (Mukherjee et al., 1995). The acquisition of CT
images in register with the experimental PET images facilitated the atlas
registration considerably, since skull landmarks (readily detected with CT)
could be directly mapped to the atlas coordinate space (which is based
on the same skull landmarks). Use of MRI in combination with PET is an
emerging new approach (Judenhofer et al., 2007). In our analyses, we
demonstrate an indirect MRI-based co-registration procedure. With this
procedure, the data sets were aligned to a common MRI template, which
in turn was registered to the 3-D atlas. In this example, the location of
the statistically signiﬁcant increased activity was found in the expected
location in the brain, in our case the amygdala following a nociceptive
conditioning (Sah et al., 2003). Finally, direct import of experimental MRI
data can be done with a high accuracy since a range of landmarks in the
brain are visible in the MRI data. Our high-resolution MnCl2/MRI examples
demonstrate the mapping of ﬁne-scale topographical organization within
thalamic sub-nuclei (see also Leergaard et al., 2003), corresponding with
previous maps of the thalamus (Fabri and Burton, 1991).
The general validity of the linear co-registration approach used in the
present study is indirectly demonstrated by the replication of known ﬁnd-
ings in the shown examples. For example, in the FGD-PET/MRI example,
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the majority of the observed PET signal is largely conﬁned to the ros-
tral part of the amygdala, in accordance with Sah et al. (2003). In the
MnCl2/MRI example, in which several anatomical landmarks were seen in
the MR images, the mean spatial displacement between anatomical land-
marks in atlas and image volume was found to be less than the size of
one voxel. This correspondence is at a level sufﬁcient to study topographi-
cal organization within sub-nuclei. The major displacement between atlas
and images in this example, not corrected for in our approach, was found
in the hindbrain. This displacement appears to be due to a dislocation
of the hindbrain occurring at the time of extraction of the brain from the
skull. Further analyses of the hindbrain would therefore require a second
step of registration in which the hindbrain is treated in isolation from the
remaining part of the brain. Adjustment for size variation alone will clearly
facilitate comparison of brain stem data from different rat brains (Brevik
et al., 2001; Leergaard et al., 2000). Thus, for tomographic material of
the quality here exempliﬁed, our linear procedures appear to provide suf-
ﬁcient accuracy to resolve most questions related to localization of data
and comparison between animals. More optimized co-registration of mul-
tiple detailed anatomical landmarks derived from histological images (Lein
et al., 2007; Toga et al., 1995) or high-resolution structural MRI (Ali et al.,
2005; Badea et al., 2007; Benveniste et al., 2000; Ma et al., 2005) would
require the use of non-linear methods.
An important feature of the 3-D atlas tool provided is the ability to
co-register image data to an atlas framework. The m3d tool supports the
import of voxel data in NIfTI ﬁle format, which allows import of volume
data such as PET, CT, and MRI. Future developments will include other
data formats. As discussed above, several approaches can be employed
for aligning image data to atlas space. In m3d, image data can be linearly
transformed (i.e., transformed with rotation, scaling, and translation) in
order to ﬁt the 3-D atlas space. The transformation matrix is calculated
based on identiﬁable landmarks in the image data. A PET image volume
typically lacks well-deﬁned structural information which may complicate
the alignment. The quality of the co-registration may be enhanced when
the researcher has access to other modalities such as MRI and/or CT.
The alignment of an MRI volume is based on anatomical landmarks such
as the outer boundaries of the brain and white matter. In a CT volume,
the deﬁnition of bregma and the interaural line provides a rigid aid in
calculating the transformationmatrix. Since the present approach is based
on linear transformations only, local alignment errors may occur due to
inter-subject variations in rodent brain shape and size. High-resolution
MRI based probabilistic atlasing of the mouse brain indicate that this
variation is relatively low (average structure volume variation coefﬁcient
in the order of 7%; Badea et al., 2007; Ma et al., 2005). Given that such
variations may be partly compensated for by linear transformations, the
need to adjust for remaining variability must be viewed in relation to the
resolution employed in the tomographic image volumes to be analyzed.
The present approach, with a common analytical environment for
experimental data and 3-D atlas reconstructions, not only facilitates direct
assignment of anatomical location, but may also be useful in the context
of generating probabilistic representations of the brain. Probabilistic maps
are typically based on manually segmented cases, but may also incorpo-
rate information from reconstructed atlases. Co-registration of manually
segmented cases into a common atlas space would thus enable the con-
struction of a probabilistic atlas, containing a priori probabilities of various
anatomical structures at each location in atlas space. Such a probabilis-
tic atlas, in combination with the image contrast properties of different
structures, can in turn be used to automate the process of anatomical
segmentation (Ali et al., 2005; Fischl et al., 2002).
A major advantage of reconstructing standard stereotaxic atlases
(rather than constructing new customized atlases) is the wide recogni-
tion and use, and the high-resolution and comprehensive nomenclature,
of these atlases. Similarly, for human brain imaging data, the frequently
used reference atlas space (Talairach and Tournoux, 1988) has beenmade
available in many different formats in order to have a common refer-
ence space in the scientiﬁc community. Digital versions of the human
brain atlas exist in three orthogonal planes with a high-speed database
server for querying and retrieving data about human brain structures over
the internet (ric.uthscsa.edu/projects/talairachdaemon.html). The present
application of the 3-D atlases of the rat and the mouse brain makes it
simpler and more reliable to use these atlases in combination with 3-D
imaging modalities, and to bring data from different modalities into the
same environment. A further challenge would be to bring different tomo-
graphic data modalities together with primarily 2-D histological or other
section-based data, such as optical imaging data and autoradiography.
At present, the skull-based stereotaxic coordinate system of Paxinos and
Watson (1982) would seem to be a suitable common reference space.
Tools availability
Information on the availability of tools and atlas data can be found at The
Rodent Brain Workbench (http://rbwb.org).
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Abstract
Background and aims.  
Neuronal events leading to development of long-term potentiation (LTP) in the nociceptive pathways may be a 
cellular mechanism underlying hyperalgesia. The opioid receptors (ORs) are widely distributed in the central 
nervous system (CNS) and play a key role in nociceptive processing and in controlling the descending 
modulatory system to the spinal cord. We use small animal positron emission tomography (PET) to examine 
how spinal LTP may induce dynamic changes in the supraspinal opioidergic system.  
Methods.  
Spinal LTP was induced by electrical high-frequency stimulation (HFS) applied to the sciatic nerve. To study 
supraspinal changes in opioid neurotransmission, we used PET and [11C]Phenethyl-Orvinol ([11C]PEO). All rats 
were scanned at baseline and 150 min after HFS, and specific binding was calculated with a reference tissue 
model.  
Results.  
A clear C-fibre LTP, i.e. increased C-fibre response and reduced C-fibre threshold, was observed 150 min after 
HFS (t-test, p<0.05, n=6). Statistical comparisons (paired t-test, HFS>baseline, p<0.05, n=8) revealed increased 
binding, relative to baseline, ipsilaterally in the amygdala, hippocampus, somatosensory cortex and superior 
colliculus, and bilaterally in the nucleus accumbens, caudate putamen and hypothalamus. Increased binding was 
interpreted as increased OR availability due to reduced opioid tonic activity.  
Conclusions.  
In a rat model of spinal LTP PET revealed dynamic changes in supraspinal opioid neurotransmission in 
structures which constitute a pain modulatory circuitry. Altered opioid activity may be related to the measured 
spinal LTP and associated abnormal pain states, and the changes in the limbic structures may connect the 
findings with an affective-emotional response.
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Introduction
Opioid peptides, such as β-endorphin, enkephalin, and dynorphin, exert their action on widely distributed opioid 
receptors (ORs). There are three major receptor subtypes, μ, δ, and κ, in addition to the opioid-receptor-like NOP 
(Henderson and McKnight, 1997). The ORs play an important role in nociceptive and antinociceptive processing 
in the brain, and in controlling the descending modulatory system to the spinal cord. In particular μ-OR 
activation has been shown to be important for the mechanisms underlying opioid analgesia (Mansour et al., 
1988). The OR-mediated neurotransmission is involved in various molecular mechanism altered in humans with 
chronic pain (for review see Przewlocki and Przewlocka (2001)).   
   
We have, in the present study, employed a long-term potentiation (LTP) model in order to investigate the 
functional role of the ORs in nociceptive processing. It has been suggested that spinal LTP induced by noxious 
stimuli contribute to chronic abnormal pain states, such as hypersensitivity, hyperalgesia, and/or allodynia (Rygh 
et al., 2005). This powerful increase in spinal neuronal excitability observed following noxious conditioning has 
been shown to last for hours (Svendsen et al., 1997). However, previous findings have revealed that the 
expression of spinal LTP is more pronounced when the connection between the brain and recording site in the 
spinal cord is eliminated (Svendsen et al., 1999; Gjerstad et al., 2001).   
 
We have recently shown that spinal LTP of synaptic strength is induced by high-frequency stimulation (HFS) 
conditioning of the sciatic nerve (Hjornevik et al., 2008).  In this animal model of noxious stimulus-induced 
LTP, we studied the effects on brain activity using small animal positron emission tomography (PET) and the 
glucose analogue 2- [18F]fluoro-2-deoxy-glucose ([18F]FDG). The study demonstrated acute effects, due to the 
noxious HFS, and more interestingly slow (after 150 min) metabolic adaptations as a result of the spinal LTP in 
the supraspinal pain modulating network. 
 
PET is the state of the art modality for quantitative studies of receptor systems in vivo, and the function of 
specific receptor systems can be investigated using highly selective receptor radiotracers. Hence, in order to 
investigate the role of the OR system, we have in the present study employed the μ- and κ-OR agonist ligand 
[11C]PEO (Schoultz et al., Submitted to J Med Chem) for monitoring changes in the availability of μ- and κ-ORs 
after induction of spinal LTP. The observed signal mainly reflects μ-binding due to the relative high abundance 
of μ-ORs (41%) compared to κ-ORs (9 %) (Mansour et al., 1988). We hypothesised that adaptations would 
occur in brain regions known to be involved in nociceptive responses, e.g. the limbic system, sensory cortex, 
thalamus, and periaqueductal grey (PAG).    
 
Using small animal PET we demonstrate dynamic changes in opioid neurotransmission in pain processing 
regions in the brain caused by the induction of spinal LTP. The findings in this study might illustrate a 
dysfunction in the OR system involved in pain hypersensitivity and hyperalgesia. 
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Methods 
The experiments were carried out with the approval of the institutional animal care committee (Regierung von 
Oberbayern, Munich, Germany) and in accordance with the German Animal Welfare Act (Deutsches 
Tierschutzgesetz). Animal husbandry followed the regulations of European Union (EU) guideline No. 86/609. 
All rats were sacrificed immediately after the experiments.   
Animals and surgery 
In all experiments, animals were anaesthetized by inhalation of isoflurane 2 % (Abbott Laboratories, Illinois, 
USA). Absence of foot withdrawal to pinch indicated adequate anaesthesia. Different animals were used in the 
electrophysiological study (female Sprague-Dawley rats (SD; Scanbur BK, Sollentuna, Sweden; National Lab 
Animal Center, Norway); 200-350 g) and the PET study (Male Wistar rats (WI; Charles River); 320-370 g). As 
previously described in Hjornevik et al. (2008), the left sciatic nerve was dissected free at the mid-thigh level 
and isolated from the surrounding tissue by a plastic film. A bipolar silver hook electrode (1.5 mm distance 
between the hooks) was placed proximal to the main branches of the sciatic nerve for electrical stimulation. 
Induction of spinal LTP was obtained by HFS conditioning (1 ms rectangular 4.5 mA pulses, five trains of 1 s 
duration, 100 Hz, 10 s intervals between trains). 
Recording of spinal field potentials 
A laminectomy was performed at vertebrae Th13-L1, corresponding to spinal cord segments L3- S1 
where the sciatic nerve roots enter the cord. The vertebral column was rigidly fixed and the meninges 
were carefully removed with a cannula. Parylene-coated tungsten microelectrodes with impedance 1.0-
1.4 M (Friedrick Haer & CO, Bowdoinham, USA) were lowered vertically into the dorsal horn of the 
spinal cord by an electronically controlled micromanipulator. The signals from the microelectrodes were 
amplified with an AC pre-amplifier, filtered with band-width 1-300 Hz, digitalized with the interface 
CED 1401μ and continuously captured on a PC with the software CED Spike 2 (Cambridge Electronic 
Design, Cambridge, UK). The C-fibre threshold was defined as the lowest stimulus intensity that evoked 
the first visible C-fibre response. Only recordings with a clear C-fibre response corresponding to the 
latency of the primary afferent C-fibres at depths of 100–300 μm from the surface of the spinal cord were 
included in the study. The C-fibre response was calculated as the amplitude of the C-fibre volley. Every 
4th minute a rectangular 2 ms test pulse with intensity of 1.2 x C-fibre threshold was delivered to the 
sciatic nerve. Three stable C-fibre responses served as a baseline for the subsequent experiment. See 
Hjornevik et al. (2008) for more details. 
 
Radiochemistry ([11C]PEO synthesis) 
The radiosynthesis of 20R)-4,5--Epoxy-17-methyl-3-hydroxy-6-11Cmethoxy-,17-dimethyl--(2-
phenylethyl)-6,14-ethenomorphinan-7-methanol 11CPEO was preformed by 11C-methylation of the 3-O-
trityl-6-O-desmethylated precursor employing a fully automated radiosynthesis module as published 
elsewhere (Schoultz et al., Submitted to J Med Chem). 11CPEO was purified by preparative high-
performance liquid chromatography. After dilution, the product fraction was immobilized on a reversed-
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phase cartridge, washed, eluted with ethanol, and diluted with phosphate buffered saline, pH 7.4. Quality 
control was performed with an analytic high-performance liquid chromatography system. The entire 
synthesis was completed within 40 min after end of bombardment. 11CPEO was obtained in a decay-
corrected radiochemical yield of 57 ± 16 % (n=18), based on [11C]MeI) and specific activity of 1622 ± 
233 mCi/mol at end-of-synthesis (EOS). The radiochemical purity was > 98%. 
PET data acquisition and image analysis 
PET and CT data were acquired by a dedicated small animal microPET scanner (Inveon, Siemens Medical 
Solutions, Erlangen, Germany). The Inveon multimodality scanner provides high sensitivity (≥10 %) and high 
spatial resolution (≤ 1.46 mm FWHM, 2D FBP) (Constantinescu and Mukherjee, 2009).  
 
Eight animals were included in this study and each animal underwent two scans; baseline and HFS. The baseline 
scans were acquired for all animals a few days prior to the intervention scan. For the HFS scans, the animals 
were stimulated according to the LTP protocol given above; 1 ms rectangular 4.5 mA pulses, five trains of 1 s 
duration, 100 Hz, 10 s intervals between trains, and scanned according to the late phase stage as reported in 
Hjornevik et al. (2008) (injection 150 min after HFS conditioning). [11C]PEO (32.64 ± 7.12 MBq) was injected 
intravenously in the tail and all animals were scanned for 60 min. Data were collected in list mode and 
dynamically reconstructed into 20 timeframes using 3DRP (Kinahan and Rogers, 1989) (128x128x159 matrix 
size, 0.78x0.78x0.80 mm3 voxel size).  
 
Activity from the lacrimal glands was removed in PMOD (PMOD Technologies Ltd., Zurich, Switzerland) and 
pixel-wise modelling using the Ichise Multi-linear Reference Tissue Method (MRTM0) (Ichise et al., 1996) was 
applied to the data. This reference model is based on the Logan Plot (Logan et al., 1996) and applies for 
reversible receptor studies. A measurement of receptor concentration, the binding potential (BPND), is calculated 
by 
Dref
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where Vt and Vref are the distribution volumes in tissue and in a reference volume which is devoid of the 
receptors of interest, respectively. Vref provides an estimation of the non-specific binding and free tracer in 
tissue, which the model assumes to be equal for all tissues. k3 and k4 describe the rates of association (per min) to 
and dissociation (per min) from the receptors, respectively. BPND is proportional with the ratio of the 
concentration of available sites (Bmax) to the in vivo equilibrium dissociation constant of the radiotracer (KD). In 
the present study, the cerebellum was chosen as a reference volume due to the lack of ORs in this region for the 
rat (Mansour et al., 1988).    
 
Statistical analysis of the parametric BPND-maps was performed with SPM5 (Wellcome Department of Cognitive 
Neurology, Institute of Neurology, London, UK). Firstly, a PET template was created from an average of 
summed images (15-60 min) of all animals. Then, intra-subject co-registration and spatial normalization to the 
customized PET template, employing a twelve-parameter affine transformation procedure, were applied to the 
summed PET images and hence the parametric BPND-maps of each animal. The parametric maps were then 
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smoothed with a 2 mm FWHM Gaussian filter, and group analysis (paired t-test, HFS vs. baseline) was 
performed. All images were normalized using grand mean proportional scaling. Significance was accepted at the 
5 % level, and inference was tested for both increased (HFS>baseline) and decreased (HFS<baseline) specific 
binding. In addition, an average BPND dataset was created from all baseline scans (n=8).  
 
The statistical significant image (p<0.05) obtained from the group analysis was first co-registered, based on the 
PET template, to a customized CT template made from an average of all CT scans (n=8). Then, based on skull 
landmarks (i.e. bregma and interaural line) visible in the CT data, the result image was aligned with a 2-D digital 
version of the Rat Brain atlas by Paxinos & Watson (2005). In addition, a Magnetic Resonance Imaging (MRI) 
template fitted to Paxinos and Watson atlas space was co-registered to the same atlas space (Schweinhardt et al., 
2003). Statistical T-values were extracted from the SPM result image by applying volumes of interest (VOIs) in 
PMOD. The spherical (1 mm radius) VOIs were placed at predefined regions, and peak and average T- and 
BPND-values within these VOIs were reported. The areas of interest were regions of significant OR density 
(Mansour et al., 1988) known to be involved in pain processing; nucleus accumbens (Acb), amygdala, 
hippocampus, hypothalamus, caudate putamen (CPu), sensory cortex, superior colliculus (SC), and regions 
where metabolic adaptations were observed in our previous study (Hjornevik et al., 2008); PAG, rostral 
ventromedial medulla (RVM), and dorsolateral pontomesencephalic tegmentum (DLPT).         
 
For visualization and localization purposes, the parametric T-maps were fitted to a 3-D atlas framework 
reconstructed from “The Rat Brain in Stereotaxic Coordinates” by Paxinos & Watson (2005) (for details, see 
Hjornevik et al., 2007). Our group has developed a multi-platform atlas tool (available via The Rodent 
Workbench, http://rbwb.org) which allows combined visualization of experimental image data and 3-D atlas 
structures. Co-registration was performed by the use of well-defined skull landmarks attainable from the CT data 
which is aligned with the PET template. These landmarks (i.e. bregma and interaural line) are the same 
landmarks that the Paxinos & Watson atlas framework is based upon. The same linear transformation obtained 
from the alignment was applied to the T-maps.       
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Results
Spinal field potential recordings 
The HFS conditioning applied to the sciatic nerve caused a long-lasting increase in neuronal excitability 
at the spinal level (Fig. 1 a,b). Notably, the data demonstrated an increase in the C-fibre response (Fig. 1 
c), but also a decrease in the C-fibre threshold (Fig. 1 d) of nociceptive dorsal horn neurons after HFS 
conditioning (Students t-test, p<0.05, 160-168 min after HFS versus baseline). 
PET measurements
The extracted T-values passing the probability threshold (p<0.05) together with baseline BPND values are listed 
in Table 1. The statistical significant results are comparisons between rest and stimulation condition within each 
animal (HFS>baseline; SPM contrasts [1 -1]). No significant results were found for decreased BPND values 
(HFS<baseline; SPM contrast [-1 1]). The listed BPND values represent specific binding of [11C]PEO to μ-ORs, 
and to a lesser degree, κ-ORs in selected tissues relative to a reference region (i.e. cerebellum). No ORs are 
located in the rat cerebellum (Mansour et al., 1988), which therefore was used to estimate the extent of non-
specific binding and free tracer in tissue. The statistical significant result image was superimposed onto the 2-D 
digital atlas (Fig.2 g-l) and a reference MRI template (Fig.2 a-f) for localization of the predefined VOIs.    
 
An increase in BPND due to the noxious conditioning stimulation was observed in the ipsilateral amygdala (Fig. 2 
d,j) and adjacent cortical areas. No increased BPND was observed on the contralateral side in these regions. 
Similarly, increased specific binding was observed at two individual locations in the hippocampus, exclusively 
on the ipsilateral side (Fig. 2 d,e,j,k). At a more caudal level, an area of significant signal was located in the 
ipsilateral SC (Fig. 2 f,l). Specific binding was also registered in the somatosensory cortex on the ipsilateral side 
(Fig. 2 c,i). The relative high T-value (peak= 3.16) witnesses a strong effect in this cortical region. An increased 
BPND was also observed through several levels of the CPu (Fig. 2 a-c,g-i). The significant signal was located 
bilaterally, but with a higher effect on the ipsilateral side (Table 1). Another region with a bilateral signal 
localization was the Acb (Fig. 2 a,g). This area had the strongest effect (peak T-value= 4.82).  
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Discussion and conclusions 
In the present study, we show for the first time that in an animal model of spinal LTP, which is likely to 
represent an increased excitability in the ascending pain pathways from the spinal cord to the brain stem, also 
results in dynamic changes in OR binding in brain regions involved in pain processing. Below, we discuss the 
specific findings of the different sites of the CNS and how our findings might influence nociceptive processing.  
 
Methodological considerations 
LTP is a well used model for studying cellular memory of nociception, and the long-lasting increase in synaptic 
activity has been observed independently of sex and rat strains (Gjerstad et al., 2001; Vikman et al., 2003) . 
Previous data show that the operation for isolating the sciatic nerve never causes any increase in neuronal 
excitability neither at the spinal level nor in the brain (Rygh et al., 1999; Hjornevik et al., 2008). Hence, the 
spinal LTP and the subsequent supraspinal functional changes in the present study are directly related to the 
electrical repetitive stimulation, i.e. the HFS conditioning.  
  
The BP was calculated using a reference tissue model, and although these methods do not provide a full kinetic 
analysis, they are able to estimate valuable measures of interest. In the present study, group comparison between 
HFS and baseline (HFS>baseline) revealed increased BPND values in supraspinal regions 150 min after 
conditioning. Increased binding can be interpreted as reduced endogenous opioid peptide release or an increase 
in OR availability (Bmax) or both. The existence of a baseline tonic activity in the endogenous opioid system was 
suggested by Gestreau et al. (2000). Previous studies have demonstrated reductions in the tonic activity resulting 
in an increase in OR availability following spontaneous epileptic seizures (Hammers et al., 2007), and in 
negative affective states in human (Zubieta et al., 2003). Thus, the density of ORs available at the cell plasma 
membrane may not be constant, and the G protein-linked receptors can either be newly synthesized or recycled. 
A study by Gross-Isseroff et al. (1990) showed significantly increased μ-OR density in brains of suicide victims. 
In order to fully understand these concepts, further studies involving PCR and immunohistochemistry should be 
applied in order to determine the regulation/dysregulation of opioidergic signalling mechanisms. In any case, the 
higher binding of PET tracer observed in the present study represents a state of the OR system which is 
associated with C-fibre LTP, pain hypersensitivity, and hyperalgesia.  
 
Regional increase in specific binding 
One of the most significant regions with increased BPND was the ipsilateral amygdala (Table 1). Amygdala is 
part of the limbic network and therefore involved in the affective-motivational dimensions of pain processing 
(Davidson, 2002). One main function is to coordinate emotional and autonomic responses to noxious stimuli. In 
addition, amygdala contributes to memory formation and learning through its reciprocal projections to 
hypothalamus, thalamus, hippocampus, and the cerebral cortex (Price, 2003). Amygdala also plays an important 
role in the descending pain modulation circuitry, through direct reciprocal connections to the PAG, and indirect 
connections to the RVM (Fields and Basbaum, 1999). Antinociception is either activated through physiological 
factors (e.g. fear) or by introduction of exogenous opioids (Oliveira and Prado, 1994; Pavlovic and Bodnar, 
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1998). The medial and lateral nuclei of the amygdala contain a high concentration of μ- and δ-ORs (Mansour et 
al., 1988), while κ-OR are the sole OR located in the central nucleus. The observed ipsilateral effect is in 
agreement with the findings by Manning (1998), who reported an ipsilateral topography of pain control circuits 
including the amygdala, hypothalamus, PAG, RVM, and the dorsal horn of the spinal cord after an unilateral 
inactivation of the central amygdala. The strong effect observed might indicate a dysfunction in the 
antinociceptive properties of amygdala.  
 
Increased binding was also observed in the hypothalamus (Fig. 2 c,i). As previously mentioned, hypothalamic 
regions have reciprocal connections to the amygdala and therefore contribute to the coordination of sensory and 
autonomic information. Hypothalamus is also involved in pain modulation through descending projection to 
PAG, RVM, and the dorsal horn of the spinal cord (Fields & Basbaum, 1999), and injection of opioids into this 
regions have been reported to induce behavioural antinociception (Manning and Franklin, 1998).  
 
Two distinct areas of increased BPND were observed in the hippocampus (Fig. 2 d,e,j,k). Cortical inputs to 
hippocampus contribute to cognitive functions while subcortical modulatory inputs affect the behavioural state 
of an organism (Amaral and Lavenex, 2007). As part of the limbic system, hippocampus is involved in emotions, 
memory formation, and learning. Hippocampus is connected to various brain regions including the thalamus, 
amygdala, hypothalamus, and cerebral cortex, and contains a dense distribution of ORs, in particular μ-ORs 
(Mansour et al., 1988). An involvement of hippocampus suggests an affective and emotional response to the 
applied noxious stimuli, together with a role in memory formation in the nociceptive pathways. 
 
ORs are widely distributed throughout the basal ganglia, in particular in the CPu and Acb (Mansour et al., 1988). 
Increased binding was observed in these regions and adjacent cortical structures (Fig. 2 a,b,g,h). In contrast to 
previously discussed structures, the effect was distributed bilaterally (Table 1). The basal ganglia are involved in 
motor, cognitive, and limbic functions. Acb is part of the ventral striatum, linked with the cortex, hippocampus, 
amygdala, and hypothalamus (Groenewegen et al., 1991), and known for its role in emotion and behaviour. As 
part of the dorsal striatum, CPu receives information in particular from the cerebral cortex (Gerfen, 2004). 
Processed information from the basal ganglia is projected to brain regions such as thalamus and brain stem 
regions (e.g. superior colliculus (SC)) (Bolam et al., 2000). 
 
In addition to projections from the basal ganglia, SC also receives nociceptive inputs from spinomesencephalic 
neurons (Willis et al., 2004). This pathway, which also includes PAG, is believed to play an important role in the 
motivational-affective aspect of pain, and contributes to descending antinociception. The SC has a dense 
population of μ-OR and a moderate distribution of κ-OR (Mansour et al., 1988). The observed ipsilateral effect 
(Fig. 2 f,l) correlates with the ipsilateral pain modulating topography previously described. The observed binding 
located in this region further strengthens the hypothesis regarding a dysfunction in the descending pain inhibitory 
system.    
 
Increased BPND was also observed in the ipsilateral somatosensory cortex (Fig. 2 c,i). Even though it is known 
that the cerebral cortex plays an active role in nociceptive processes (Millan, 2002; Ohara et al., 2005), the role 
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of the somatosensory cortex is not clearly understood. In Bushnell et al. (1999), strong evidences are listed 
which support the modulating role of S1 in sensory aspects of pain. Although the OR BP is low in the primary 
somatosensory cortex (S1) in humans (Baumgartner et al., 2006), S1 has a relevant proportion of OR in rats (see 
Table 1). In the present study, it is clearly shown that the opioid neurotransmission in the somatosensory cortex 
is involved in the expression of spinal LTP induced by noxious conditioning.     
 
In our previous study (Hjornevik et al., 2008), metabolic adaptations were observed in major regions involved in 
the descending pain modulating circuitry (i.e. PAG, RVM, and DLPT).  However, no significant changes in 
BPND were observed in these regions in the present study. PAG is a relative small brain region in size with low 
abundance of ORs (Mansour et al., 1988). The low number of ORs and the signal-to-noise ratio due to small 
volume might explain the negative findings in this region. Moreover, a reduced activation in the brain stem areas 
which control the descending antinociceptive system may not necessarily involve a brain stem change in the 
opioid peptide release and/or an increase in OR concentration. Many other transmitters may be important for the 
descending seretonergic, noradrenergic, and enkephalinergic descending modulatory tone.  
 
Interestingly, increased tracer binding was observed in the amygdala, hypothalamus, hippocampus, and Acb, all 
so-called limbic structures which are involved in processing emotions, mood, motivation and pain sensations. 
Together with hippocampus, amygdala is involved in learning and memory of noxious stimuli. In particular, 
amygdala plays a major role in associating the stimuli with emotions. A recent study demonstrated that positive 
emotions were related to increased opioid release in amygdala, and OR BP was negatively correlated with 
positive mood (Koepp et al., 2009). Their findings fit with the present results where a negative emotional state 
following a noxious stimulus resulting in a spinal LTP is associated with increased OR binding. The involvement 
of these structures indicates both an affective-emotional response to the applied noxious stimuli and possible 
functional alterations in the pain modulatory circuitry.     
 
Release of endogenous peptides in the brain predominantly inhibits nociceptive transmission. A reduced activity 
in this system may therefore reflect an insufficient inhibition in the supraspinal antinociceptive system. Clearly, 
this may also influence the descending bulbospinal pathways to the dorsal horn. Previous studies have shown 
that the expression of spinal LTP after 2.5 h is more pronounced when the connection between the brain and the 
recording site in the dorsal horn is eliminated (Svendsen et al., 1999; Gjerstad et al., 2001). This shows that 
maintenance of spinal LTP can be reinforced by a reduction in the descending inhibition. 
 
In accordance with these data, we here demonstrate that the noxious conditioning leading to an altered state of 
the OR system is associated by both an increased C-fibre response as well as a reduced C-fibre threshold. Hence, 
it is tempting to speculate that spinal LTP may involve a reduced tone in the descending inhibitory pathways. 
The fact that sensitization at the spinal level induced by noxious stimuli and development of persistent 
hyperalgesia can be modulated by descending pathways to the spinal cord, has also been demonstrated in 
humans (Matre et al., 2006).  
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Behaviour studies have shown that induction of spinal LTP is followed by a long-lasting ipsilateral reduction of 
paw withdrawal latency, i.e. hyperalgesia (Zhang et al., 2005).  Moreover, a perceptual correlate to LTP in 
nociceptive pathways has also been described in humans (Klein et al., 2004). It is therefore likely that the 
conditioning used in the present study to induce spinal LTP may contribute to hypersensitivity, hyperalgesia, 
and/or allodynia, mechanisms seen in central sensitization (Sandkuhler and Liu, 1998; Rygh et al., 2005). 
However, whether development of persistent hyperalgesia after this form of conditioning may be caused by a 
local spinal increase in synaptic efficacy or changed supraspinal processing, including a reduced tone in the 
descending inhibitory pathways, remains to be investigated.  
 
Concluding statements    
The data shows that HFS is associated with a regional increased OR availability that is interpreted as reduced 
opioid tonic activity. The involved structures, amygdala in particular, constitute a pain modulatory circuitry. 
Therefore, a reduced descending opioid, antinociceptive activity may be related to states of abnormal pain 
sensitivity, such as hyperalgesia. Furthermore, the dynamic changes in opioid neurotransmission in the limbic 
structures may connect the findings with an affective-emotional response to the applied noxious stimulus.  
 
Strong natural noxious stimuli (e.g. skin burns, contusions, inflammation, and acute nerve injury) which may 
induce spinal LTP (Sandkuhler and Liu, 1998), also trigger injury-induced hyperalgesia. Consequently, spinal 
LTP is an attractive and relevant animal model of central sensitization and hyperalgesia, which can be studied 
with small animal PET. The obtained results may contribute to the understanding of how chronic pain develops 
and potentially enables us to target an improved treatment of patients with chronic pain.    
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Legends 
 
Fig. 1 Extracellular field potential recordings, C-fibre responses and threshold  
(a) Extracellular field potential recordings at baseline and 168 min after HFS conditioning. C-fibre responses 
represented as a percentage of baseline, plotted as a function of time (min) relative to HFS conditioning (b), and 
as bar diagrams at two time points; baseline and 160-168 min after HFS conditioning (c). (d) Bar diagrams 
showing the C-fibre threshold at two timepoints; baseline and 168 min after HFS conditioning. The increased C-
fibre responses and reduced C-fibre threshold relative to baseline are statistical significant (p<0.05). HFS, high 
frequency stimulation; *, statistical significant results (p<0.05).  
 
Fig. 2 Regional increase in specific binding  
Brain regions with increased specific binding after comparison between HFS and baseline. The statistical 
significant PET signals (p<0.05; colors) are overlaid on a digital versions of the Paxinos & Watson the rat brain 
atlas (a-f), and on a MRI template (g-l). Left side in the image represents the left side of the brain. Increased 
specific binding was observed in the nucleus accumbens (a,g), caudate putamen (b,h), somatosensory cortex 
(c,i), hypothalamus (c,i), hippocampus (d,e,j,k), amygdala (d,j), and superior colliculus (f,l). Blue: a slight 
increase (low T-value) in specific binding; red: a high increase (high T-value) in specific binding. Red circles, 
volumes of interest (VOIs); Bar, 1 mm. 
 
Fig. 3 Alignment and localization of PET data with a 3-D digital atlas system (Atlas3D)  
(a) 3-D atlas structures reconstructed from Paxinos & Watson (Paxinos & Watson, 2005) and visualized in 
Atlas3D. (b) CT template with skull landmarks (i.e. bregma and interaural line) used for alignment with 3-D 
atlas space. (c) CT template and SPM result image coregistered to atlas space based on the transformation matrix 
obtained from the CT alignment. Area of significant binding is shown in blue. (d) Coronal atlas diagram locating 
the significant signal to the hippocampus, amygdala, hypothalamus, and somatosensory cortex. S1, primary 
somatosensory cortex; hi, hippocampus; am, amygdala; hy, hypothalamus.  
 
 
Baseline BPND T-value 
Region
Peak Average Peak Average
S1, left 1,51 1,17 3,16 2,47 
S1, right 1,55 1,19 - - 
Amygdala, left 1,40 1,03 4,03 3,35 
Amygdala, right 1,52 1,15 - - 
Acb, left 1,89 1,53 4,82 2,93 
Acb, right 1,93 1,59 3,48 1,37 
Hypothalamus 1,81 1,26 3,31 1,56 
SC, left 2,06 1,81 2,41 1,66 
SC, right 2,13 1,86 - - 
Hippocampus, left 1,24 0,84 3,88 1,86 
Hippocampus, right 1,32 0,88 - - 
CPu, left 2,12 1,88 2,59 1,00 
CPu, right 2,07 1,87 3,35 1,51 
Cerebellum 0,36 0,36 - - 
Table 1. Baseline BPND and T-values extracted from predefined volumes of interest. Group results from 
studies of [11C]PEO binding by means of PET, where average and peak T- values were extracted from volumes 
of interest (VOIs) passing the predefined probability threshold of p<0.05 and regions outside the VOI at 
p<0.001. T-values are obtained from group comparisons between baseline and stimulation condition within each 
animal (SPM contrasts [-1 1]). BPND values represent the average binding potential within the VOIs from all 
baseline scans (n=8). BPND, binding potential; S1, primary somatosensory cortex; Acb, nucleus accumbens; SC, 
superior colliculus; IC, inferior colliculus; CPu, caudate putamen; 
Figure 1
Figure 2
Figure 3
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Abstract  
Purpose The recent development in radiosynthesis of the 11C-carbamate function increases the potential 
of 11CGR103545, which for last decade has been regarded promising for imaging the kappa-opioid 
receptor (-OR) with PET. In the present study, 11CGR103545 was evaluated in awake rhesus 
macaques. Separate investigations were performed to clarify the OR-subtype selectivity of this 
compound.  
Methods Regional brain uptake kinetics of 11CGR103545 was studied 0-120 min after injection. The 
binding affinity and opioid subtype selectivity of 11CGR103545 was determined in cells transfected 
with cloned human opioid receptors.  
Results In vitro binding assays demonstrated a high affinity of GR103545 for -OR (Ki=0.02 nM) with 
excellent selectivity over -OR (6102 fold) and) -OR (2104 fold). PET-imaging revealed a volume 
of distribution (VT) distribution pattern consistent to that previously reported from studies with  
11CGR103545 in anesthetized primates, with striatum = temporal cortex > cingulated cortex > frontal 
cortex > parietal cortex > thalamus > cerebellum, but VT obtained in the present study was significantly 
higher for all brain regions.  
Conclusions 11CGR103545 is selective for -OR and may allow a selective depiction and 
quantification of this receptor in humans by means of PET. 
Keywords Opioid receptor, kappa, PET-imaging, carbon-11, GR103545.   
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Introduction
Among the opioid receptor (OR) subtypes (,  and ), the -OR has the highest concentration (37%) 
in the human CNS, with particularly dense expression in the forebrain, midbrain, and brainstem 
structures 1. The -OR is a potential target for therapeutic intervention of several psychiatric and 
neurological diseases, such as epilepsy, pain and drug addiction 2-7. An increased understanding of 
how occupancy of this receptor affects -OR mediated neurotransmission will facilitate development of 
-OR-directed drugs and diagnostic tracers. No -OR-selective tracer is currently available for routine 
clinical application. 
Radiolabelling and brain uptake studies in mice of racemic 11C]GR89696, a highly potent and 
selective -OR agonist 6, was reported in 1999 by Ravert and coworkers 7. The same group later 
reported the separate in vivo evaluation of the R- and S-enantiomers of 11CGR89696 in the mouse, and 
demonstrated that the regional brain uptake of the R-isomer, also known as [11C]GR103545, correlates 
with the distribution of -OR 8. More recently, Talbot and co-workers evaluated 11CGR103545 in 
non-human primates and found the regional binding pattern of 11CGR103545 to be in excellent 
agreement with the known distribution of -OR in the non-human primate brain 9.   
Translation of 11CGR103545 to clinical trials has so far been hampered by lack of an efficient 
radiosynthesis. Previously, 11CGR103545 has been produced by reduction of 11CCO2 to 
11CCH2OH, followed by treatment of 11CCH2OH with phosgene, and finally reaction with des-
carbamate-GR103545 7-9. We recently reported an improved method for 11C-labeling of carbamate 
groups based on the three-component coupling reaction (Fig. 1) of amines, CO2 and [11C]methyl-triflate 
10. The method enables labeling of11CGR103545 in excellent yields under mild conditions, with a 
total synthesis time of ~25 min after end-of-bombardment 10.   
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Here we report PET-studies of 11CGR103545 in awake rhesus macaques using the improved 
radiosynthesis of this tracer, as well as in vitro binding studies for investigating the OR-subtype 
selectivity and binding profile of this compound.  
Materials and methods
Tracer Preparation 
The radiosynthesis of 11CGR103545 was performed as previously described 10.  
PET Experimental Procedures 
Experiments were performed according to protocols approved by the Institutional Animal Care and Use 
Committee of The Medical and Pharmacological Research Center Foundation Hakui-city Ishikawa as 
previously reported 11. Three male Rhesus Macaques (8.9, 8.1 and 6.5 kg, respectively), fasted for 4 
hours prior to the scan were maintained in awake condition for the study and received 550.0 ± 148.0 
MBq of 11CGR103545 with a specific activity of 50.7 ± 7.9 GBq/mol at time of injection. Two 
animals were scanned a second time, after injection of 210 and 450 MBq of 11CGR103545, 
respectively, with a specific activity 26.8 ± 5.3 GBq/mol at time of injection.  
For collection of arterial blood samples, a catheter was inserted in a femoral artery under 
transient anesthesia condition induced by 2% sevoflurane in a N2O and O2 gas mixture (N2O:O2 7:3).  
PET-scanning was performed with an SHR-7700 (Hamamatsu Photonics, Hamamatsu, Japan) in 
2-dimensional mode. A 30-min transmission scan was obtained before radiotracer injection for 
attenuation correction. 11CGR103545 was administered by intravenous injection over 30 s and 
emission data were collected 0-120 min post-injection (p.i).  
Arterial samples obtained from the animals were collected at 0, 10, 20, 30, 40, 50 sec, 1, 2, 3, 5, 
7, 10, 15, 20, 30, 45, 60, and 90 min. Eight samples, collected at 1, 5, 10, 20, 30, 45, 60, and 90 min 
p.i., were analyzed by thin layer chromatography (TLC) to determine the percentage intact tracer. Here, 
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0.1 ml of acetonitrile was mixed with plasma samples (0.1 ml), and centrifuged for 3 min at 12.000g. 
The resulting supernatant was applied to a TLC-plate which in turn was developed in 
chloroform:methanol: 25 % NH4OH (91:8:1 (v/v)). The TLC-plate was subsequently exposed to an 
imaging plate (Fuji Film, Tokyo, Japan). Finally, the imaging plate was analyzed by an imaging plate 
reader (BAS1800, Fuji Film).  
A bi-exponential function was fitted to the 8 points representing the percentage intact tracer, and 
was used to interpolate values between and after the measurements. The input function was calculated 
as the product of total counts and interpolated parent fraction at each time point. The metabolite 
corrected input function values were fitted to a sum of three exponentials and the resulting fitted values 
used as input for the kinetic analyses.  
The plasma free fraction (f1) was determined by ultrafiltration of triplicate 0.2-ml aliquots of 
plasma. The amount of radioactivity in the filter unit and in the filtrate was measured. F1 was calculated 
as the ratio of the concentration of radioactivity in the filtrate relative to the total.   
Peripheral clearance (l/h), i.e. washout from plasma, was defined as the ratio of injected dose to 
the area under the curve of the metabolite corrected input function.  
 
Image Analysis  
Fourty-one successive frames of increasing duration (18  10 s, 7   1 min, 16   5 min) were 
reconstructed using a filtered back-projection (Hanning filter, 4.5 mm FWHM). Reconstructed images 
were anatomically standardized using a macaque version of NEUROSTAT (University of Washington, 
Seattle, WA). Regions of interest (ROIs) were set based on anatomically standardized images for 
cerebellum, cingulate, frontal cortex, parietal cortex, temporal cortex, striatum and thalamus. Right and 
left regions were averaged for the generation of time-activity-curves (TACs).  
Regional total distribution volume (VT; ml/g) were derived by kinetic analysis of the regional 
TACs, using the metabolite-corrected arterial plasma concentrations as input functions, according to a 
 
5
1- or 2-tissue-compartment model (PMOD Technologies Ltd., Zurich, Switzerland). VT was derived 
from kinetic parameters in the 1-tissue-compartment model (1TCM) as: 
2
1
k
KVT   
and in the 2-tissue-compartment model (2TCM) as: 
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 Best model fit was calculated using the Akaike information criterion (AIC) (12) and statistical 
comparison (paired t-test) of the mean value of all the regions in each scan of each animal. 
 The binding potential, BPND, refers to specific binding of ligand relative to the nondisplaceble 
(non-specically bound and free ligand) concentration in tissue. This parameter can be derived from: 
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where VT(ref) represents VT in a reference region devoid of the particular receptor of interest. In order to 
compare our results with Talbot et al. [9], cerebellum was employed as reference region. In addition to 
the plasma input modeling, a reference tissue model, Ichise's Multilinear Reference Tissue Model 2 
(MRTM2), with cerebellum as a reference region was applied to estimate BPND. ROI based kinetic 
modeling was applied for the parameter estimations while pixel-wise modeling was used for 
visualization purposes. 
 
Determination of inhibition constants of GR103545 for binding to opioid receptors 
The OR-binding profile of GR103545 was determined in radioligand binding experiments in vitro using 
ORs stably expressed on cloned cells: Human recombinant HEK-293 cells expressing -OR, CHO-K1 
cells expressing -OR, and CHO cells expressing -OR according to published procedures 13-15.  
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Results
PET-Scanning 
For the total of 5 scans conducted, the injected activity of 11CGR103545 was 462.0 ± 180.8 MBq 
(mean ± SD) and the specific activity 41.8 ± 13.4 GBq/μmol. The amount of substance injected was in 
the range 1.15-1.71 nmol/kg body weight (0.47-0.71 g/kg body weight).  
All metabolites observed in the analysis of radioactivity in plasma were polar species that are 
not likely to be taken up in the brain. Plasma metabolite analysis after the injection of [11C]GR103545 
revealed no lipophilic metabolites. The fraction of total plasma activity corresponding to the parent 
compound at 1, 5, 10, 20, 30, 45, 60, and 90 min after injection of [11C]GR103545) was 92 ± 3, 80 ± 5, 
67 ± 7, 54 ± 7, 49 ± 8, 38 ± 12, 35 ± 12, 30 ± 11 %, respectively (n=5).  
f1 and peripheral clearance for [11C]GR103545 were 22 ± 7 % and 20.4 ± 5.1 L/hrs, respectively 
(n=5).  
 TACs of [11C]GR103545 in rhesus macaques (n = 4) are displayed in Fig. 2. The lowest level 
of radioactivity was found in the cerebellum, where the TAC reached a distinct maximum at approx. 
1200 s followed by a slow washout. The activity in regions with high κ-OR density, such as cingulated-
, parietal and frontal cortex, together with striatum, reached a higher maximum later in time and 
remained at a constant level until the end of the examination. 
 Compared to the corresponding data from Talbot et al. 9, we observed a slower wash-out in 
regions with low and intermediate κ-OR binding of [11C]GR103545 in the present study. 2TCM was 
chosen as the method of choice due to the lowest AIC value, and the calculated VT  (Table 1 and Fig. 2) 
resulted in the following rank of uptake: striatum = temporal cortex > cingulate cortex > frontal cortex 
> parietal cortex > thalamus > cerebellum. For all brain regions evaluated in this study, VT is 
significantly higher compared to those of Talbot et al. 9 (Table 1). There was no significant effect of 
the mass of injected ligand on the calculated VT neither in the high κ-OR density region cingulate 
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cortex (R=0.10, p = 0.24), nor in the cerebellum (R = 0.22, p=0.27), where there is a low concentration 
of κ-OR.  
The estimated BPND for the ROIs are listed in Table 2. The first two columns display the BPND 
values calculated by two different methods; by 2TCM with plasma input and by MRTM2 with a 
cerebellum TAC input function. Cerebellum is used as a reference region in order to compare our 
results with the BPND values presented by Talbot et al. [9] (column 3). In general, the BPND obtained in 
the present study are lower than the results from Talbot et al. [9]. The use of cerebellum TAC as an 
input function (column 2) resulted in lower BPND values compared to plasma input (column 1).  
Determination of binding affinity to opioid subtype receptors
GR103545 showed a high affinity to -OR (Ki = 0.02 nM) and excellent selectivity for -OR over -
OR (Ki = 16 nM) and over -OR (Ki = 530 nM).  
 
Discussion
Several OR tracers are available for use in PET and have been investigated in animal models and 
clinical studies. Although 18Ffluorocyclofoxy 16, 11Cdiprenorphine 17 and 18Ffluoroethyl 
diprenorphine 18 possess sub-nanomolar to low-nanomolar affinity for -OR, their cross-reactivity to 
 and -, respectively, is limiting their usefulness. A -OR selective PET-tracer is needed for a high 
sensitivity detection of changes to the availability of -OR in vivo.  
Previous studies of the opioid subtype selectivity of methyl 4-[(3,4-dichlorophenyl)acetyll-3-[(l-
pyrrolidinyl)methyl-l-piperazinecarboxylate, which were based on in vitro investigations of (±) 
GR89606 in brain tissue of rhesus monkeys,  found only a low selectivity for -OR over -OR 19. 
This prompted us to investigate the binding of GR103545 human opioid receptors, stably expressed on 
transfected cells. In these assays, GR103545 displays an excellent selectivity for -OR over -OR 
(6102 fold) and -OR (2104 fold). A broad receptor screening binding assay (MDS Pharma Services, 
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Taiwan) covering more than 30 receptors and subtypes found no cross-reactivity at 100 nM 
concentration, suggesting that GR103545 is highly selective for the -OR. Furthermore, the regional 
brain uptake of 11CGR103545 in rhesus macaques found in the present study, and in baboons as 
reported by Talbot et al. 9, correlates with the known expression pattern of -OR 1. These results, as 
well as the receptor binding profile reported herein, provide a strong support of the -OR–selective 
profile of 11CGR103545.  
  The new method for 11C-labeling of the carbamate functionality in 11CGR103545 is based on 
11CMeOTf 10, a prosthetic labeling reagent which is routinely produced at PET radiochemistry 
laboratories with an on-site cyclotron. The high-yielding 11C-methylation of [11C]GR103545 was 
readily automated using a synthesis module, and provides the tracer with a specific activity of 1792 ± 
312 mCi/μmol at end-of-synthesis 10. In this study, the production of 11CGR103545 was obtained 
with approx. 40 % of the specific activity of the 11CMeOTf employed for the 11C-methylation. The 
specific activity of the 11C-methylation agent is therefore the limiting factor for the specific activity of 
the tracer, as opposed to the overall synthesis time. Although identical performance for production of 
[11C]GR103545 at the Ci-level needs to be confirmed, we expect the simple radiosynthesis to allow for 
up-scaling without major difficulties or fundamental restrictions. 
The present study confirms the correlation of the specific binding pattern of [11C]GR103545 
(Table 1.) to the known distribution of -OR in primate brain 1 and is correlating to previously 
published data [9] obtained with a comparable injected amount of compound per kg of body weight.  
However, compared to the kinetic data in the previous study 9 with similar peripheral clearance (this 
study: 20.4 ± 5.1 L/hrs; Talbot et al.: 23.3 ± 8.6 L/hrs), we observed a slower clearance kinetics, which 
indicates a higher effective ligand-receptor binding affinity, and, in accordance with this observation, 
the values of VT found in our study are significantly higher (Table 1.), even though the values of f1 of 
11CGR103545 found in the two studies are comparable (Talbot et al.: 24 ± 9); this study 22 ± 7 %). 
The higher VT may be due to species differences (this study: rhesus macaques; Talbot et al.: baboons), 
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but a more likely explanation is the absence of any anesthesia in our PET experiments. Anesthetics are 
known to inhibit high-affinity states of the OR 20, and may therefore have led to the comparably 
lower VT and faster clearance in the previous study 9.  
Calculation of binding potentials using cerebellum or occipital cortex as reference regions have 
been applied in several studies for OR ligands. This approach may simplify modeling in non-invasive 
scanning protocols, but the reference region should be devoid, or contain only a negligible 
concentration, of the receptor in question. It has been previously shown that the cerebellum of non-
human primates 1, as well as that of humans 21, has a low, but relevant proportion of -OR. The 
TAC for cerebellum (Fig. 2) indicates a low but existing number of k-OR in the cerebellar region. 
Consequently, the cerebellum is not optimally suited as a reference region for calculation of binding 
potentials of 11CGR103535 in these species. Also, occipital cortex is often used as a reference region 
for quantification of OR studies in human. However, while this region has a relative negligible 
expression of μ-OR, it contains a significant -OR density 22 which will result in an overestimation 
of nondisplacable binding. Consequently, to our knowledge, there is no ideal reference region for 
quantification of -OR binding in human, and translation of 11CGR103535 into clinical studies will 
require arterial sampling or using the activity in the carotid arteries as input function.  
 In the present study, cerebellum was used as a reference region in order to compare our results 
with Talbot et al. [9]. However, as stated above, the presence of -OR in the cerebellum will result in 
an underestimation of specific binding of 11CGR103535. As can be seen in Table 2, the calculated 
BPND is relative low compared to the kinetics illustrated by the TACs in Fig. 2. A slow washout effect 
indicates a significant amount of specific binding, particularly in regions with high -OR density (e.g. 
cingulate cortex and striatum), but also in cerebellum which contains a relative small portion of -OR. 
These results, together with the data presented by Mansour et al. [1], show that cerebellum is not the 
optimal choice as a reference region for quantification of -OR in non-human primates and humans. A 
direct calculation of BPND from the arterial input method and k3/k4 relationship is sensitive to noise. 
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Without a reference region it is necessary to perform two studies, with and without displacement of the 
tracer, in order to achieve a robust estimate of BPND. 
Because tracer kinetic in baboons indicates that this tracer is bound pseudo-irreversible, it needs 
to be clarified whether alterations in the -OR state affect the regional retention of the tracer. The 
clinical application of this tracer for the determination of -OR availability under stimulation and 
assessment of competition with exogenous agents may involve separate determination of binding at 
baseline and at stimulation.  
Conclusion 
The present study was undertaken to further evaluate the potential of 11CGR103545 as a PET 
radiotracer for imaging and quantification of the -OR. The regional brain uptake of 11CGR103545 in 
awake rhesus macaques was in excellent agreement with the known expression pattern of -OR. The 
selectivity of 11CGR103545 for the -OR was further supported by binding studies in cells transfected 
with cloned human opioid receptors. We conclude that the potential 11C]GR103545 as a lead candidate 
for imaging of -OR in humans is strengthened.  
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Table 1. Volume of Distribution Estimatesa of 11CGR103545 in Awake Rhesus Macaques  
 
 Present study Talbot et al. 2005 
 Vt, ml/g Vt, ml/g 
Unpaired t-test  
2 degrees of freedom 
Region mean SD mean SD t p < 
Cerebellum 8.3 1.6 3.7 1.6 5.0 0.020 
Cingulate 18.9 4.8 10.9 6.1 4.7 0.025 
Frontal Cortex 16.2 3.9 8.5 3.7 5.4 0.020 
Parietal Cortex 14.4 3.2 7.5 3.8 5.1 0.020 
Temporal Cortex 20.5 2.9 8.1 4.3 4.1 0.050 
Striatum 20.5 8.2 10.5 5.9 5.1 0.020 
Thalamus 11.4 1.8 6.9 3.6 3.9 0.050 
 Mean 14.8 3.8 8.0 4.1 4.7 0.025 
 
aFitting and calculation of volume of distribution, Vt, using 2-tissue compartment model. The goodness of fit to the data, as 
indicated by the Akaike information criterion, was significantly better for the 2-tissue compartment model (mean ±  SD: 147 
± 25) than for the 1-tissue compartment model (169 ± 17), p < 0.04, which is in agreement with the findings of Talbot et al. 
2005 [9]  The values from Talbot et al. [9] are taken from their Table 3.  
 
14
Table 2. Binding estimatesa of 11CGR103545 in Awake Rhesus Macaques.  
 
 Present study Talbot et al. 2005 
 2TCM with plasma input MRTM2 with cerebellum input 2TCM with plasma input 
 BPND BPND BPND 
Region mean SD mean SD mean SD 
Cerebellum 0.00 0.00 0.00 0.00 0.00 0.00 
Cingulate 1.34 0.15 1.03 0.06 1.90 0.40 
Frontal Cortex 1.02 0.17 0.74 0.07 1.30 0.20 
Parietal Cortex 0.84 0.23 0.57 0.07 1.00 0.20 
Temporal Cortex 0.72 0.06 0.58 0.03 1.10 0.20 
Striatum 1.60 0.73 0.99 0.10 1.70 0.50 
Thalamus 0.45 0.26 0.35 0.11 0.80 0.30 
aEstimation of BPND, i.e. specific binding of 11CGR103545 relative to nondisplaceable (free plus nonspecifically bound) 
uptake in tissue. BPND was calculated with two different methods; by 2TCM with plasma input and by MRTM2 with 
cerebellum TAC as input function. The values from Talbot et al. [9] presented in the last column are taken from their Table 
3. Cerebellum is used as a reference region in all models. 
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Figures Legends 
Fig. 1. Radiosynthesis of 11CGR103545   
Fig. 2. 11CGR103545 uptake in awake rhesus macaques 
A. VT-images calculated using pixelwise 2TCM, and co-registered to a MRI template for anatomical reference. The 
horizontal slices show high VT in the cingulate and frontal cortex. Red areas, high VT; Blue, low VT. B. Average regional 
radioactivity concentration, expressed as the standard uptake value (SUV; radioactivity concentration (MBq/mL)/injected 
dose (MBq)/body mass (g)) plotted against time (n = 4). Regions with low and intermediate activity (i.e. cerebellum and 
thalamus) reach an early maximum and have a slow washout effect. Regions with high κ-OR density (cingulate and frontal 
cortex, and striatum) reach a maximum later in time, and show no significant washout effect.  
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Fig. 1. Radiosynthesis of 11CGR103545   
 
 
 
Fig. 2. 11CGR103545 uptake in awake rhesus macaques 
A. VT-images calculated using pixelwise 2TCM, and co-registered to a MRI template for anatomical reference. 
The horizontal slices show high VT in the cingulate and frontal cortex. Red areas, high VT; Blue, low VT. B. 
Average regional radioactivity concentration, expressed as the standard uptake value (SUV; radioactivity 
concentration (MBq/mL)/injected dose (MBq)/body mass (g)) plotted against time (n = 4). Regions with low and 
intermediate activity (i.e. cerebellum and thalamus) reach an early maximum and have a slow washout effect. 
Regions with high κ-OR density (cingulate and frontal cortex, and striatum) reach a maximum later in time, and 
show no significant washout effect.  
 
 
 
 
 
 
 
 
 
 
 
 

